Imino sugars and glycosyl hydrolases: Historical context, current aspects, emerging trends

Advances in Carbohydrate Chemistry and Biochemistry

Volumn 66, Issue 1, 2011, Pages 187-298

  Stütz, Arnold E ^a   Wrodnigg, Tanja M ^a  

^a GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEOXYNOJIRIMYCIN; 5 AMINO 5 DEOXY DEXTRO GLUCOSE; ALPHA GALACTOSIDASE; ALPHA GLUCOSIDASE; ALPHA LEVO FUCOSIDASE; ALPHA MANNOSIDASE; AMINE; AMINOSUGAR; ANHYDROCONDURITOL; BETA GLUCOSIDASE; BETA N ACETYLHEXOSAMINIDASE; BROMOCONDURITOL; CALYSTEGINE; CARBOHYDRATE; CARBOXYL GROUP; CASTANOSPERMINE; CYCLOPHELLITOL; FLUORODEOXYGLUCOSE; GLYCOPROTEIN; GLYCOSIDASE; GLYCOSIDASE INHIBITOR; HYDROXYL GROUP; ISOFAGOMINE; MANNOSIDASE INHIBITOR; NUCLEOSIDASE; PALYTOXIN; PYRROLIDINE DERIVATIVE; PYRROLIZIDINE DERIVATIVE; SORBITOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; ENZYME INHIBITOR; IMINOSUGAR;

ALLOSTERISM; ARTICLE; BINDING AFFINITY; BINDING SITE; BIOCHEMISTRY; CATALYSIS; ENDOPLASMIC RETICULUM; ENZYME ACTIVE SITE; GOLGI COMPLEX; HYDROPHOBICITY; MICHAEL ADDITION; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTON TRANSPORT; SIGNAL TRANSDUCTION; STEREOCHEMISTRY; X RAY DIFFRACTION; ANIMAL; BIOCATALYSIS; CHEMISTRY; DRUG ANTAGONISM; HUMAN; METABOLISM; REVIEW;

ANIMALS; BIOCATALYSIS; ENZYME INHIBITORS; GLYCOSIDE HYDROLASES; HUMANS; IMINO SUGARS;

EID: 84858771103     PISSN: 00652318     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385518-3.00004-3.     Document Type: Article

References (413)

1. R. S. Cahn, C. Ingold, and V. Prelog, Specificity of molecular chirality, Angew. Chem. Int. Ed., 5 (1966) 385-415.
2. E. J. Corey, Total synthesis of prostaglandins, Ann. N. Y. Acad. Sci., 180 (1971) 24-37.
3. E. J. Corey and W. T. Wipke, Computer-assisted design of complex organic syntheses, Science, 166 (1969) 178-192.
4. E. J. Corey and D. Seebach, Synthesis of 1,n-dicarbonyl derivatives using carbanions from 1,3-dithianes, Angew. Chem. Int. Ed. Engl., 4 (1965) 1075-1077.
5. R. Hoffmann and R. B. Woodward, Selection rules for concerted cycloaddition reactions, J. Am. Chem. Soc., 87 (1965) 2046-2048.
6. Y. Kishi, F. Nakatsubo, M. Aratani, T. Goto, and S. Inouye, Synthetic approach towards tetrodotoxin. II. A stereospecific synthesis of a compound having the same six chiral centers on the cyclohexane ring as those of tetrodotoxin, Tetrahedron Lett., 11 (1970) 5129-5132.
7. I. Dyong and N. Jersch, Synthesis of important carbohydrates. 18. The vic-cis-oxyamination as the key reaction for amino sugar syntheses: Methyl N-acetyl-4-epi-α-garosaminide, Chem. Ber., 112 (1979) 1849-1858.
8. I. Dyong, J. Weigand, and J. Thiem, Syntheses of biologically important carbohydrates. 33. Syntheses of unsaturated amino sugars and aminoalkyl-branched carbohydrates via sigmatropic rearrangement of trichloroacetimidates, Liebigs Ann. Chem. (1986) 577-599.
9. D. Horton and W. Weckerle, Synthesis of 3-amino-2,3,6-trideoxy-D-ribo-hexose hydrochloride, Carbohydr. Res., 46 (1976) 227-235.
10. T.-M. Cheung, D. Horton, and W. Weckerle, Preparative synthesis of 3-amino-2,3,6-trideoxy-L-lyxohexopyranose derivatives, Carbohydr. Res., 74 (1979) 93-103.
11. K. Bock, I. Lundt, and C. Pedersen, Reaction of aldonic acids with hydrogen bromide. I. Preparation of some bromodeoxyaldonic acids, Carbohydr. Res., 68 (1979) 313-319.
12. K. Bock, I. Lundt, and C. Pedersen, Amino acids and amino sugars from bromodeoxyaldonolactones, Acta Chem. Scand. B, 41 (1987) 435-441.
13. K. Heyns, J. Feldmann, D. Hadamczyk, J. Schwentner, and J. Thiem, Ein Verfahren zur Synthese von α-Glycosiden der 3-Amino-2,3,6-tridesoxyhexopyranosen aus Glycalen, Chem. Ber., 114 (1981) 232-239.
14. J. Thiem and D. Springer, Synthesis and hydrogenation studies of 3-azidohex-2-enopyranosides, precursors of the sugar constituents of anthracycline glycosides, Carbohydr. Res., 136 (1985) 325-334.
15. T. Nishikawa and N. Ishida, A new antibiotic R-468 active against drug-resistant Shigella, J. Antibiot. A, 18 (1965) 132-133.
16. S. Inouye, T. Tsuruoka, and T. Niida, Structure of nojirimycin, sugar antibiotic with nitrogen in the ring, J. Antibiot. A, 19 (1966) 288-292.
17. N. Ishida, K. Kumagai, T. Niida, T. Tsuruoka, and H. Yumoto, Nojirimycin, a new antibiotic. II. Isolation, characterisation, and biological activity, J. Antibiot. A, 20 (1967) 66-71.
18. S. Inouye, T. Tsuruoka, T. Ito, and T. Niida, Structure and synthesis of nojirimycin, Tetrahedron, 24 (1968) 2125-2144.
19. M. Koyama and S. Sakamura, The structure of a new piperidine derivative from buckwheat seeds (Fagopyrum esculentum Moench), Agric. Biol. Chem., 38 (1974) 1111-1112.
20. S. Hanessian and T. H. Haskell, Synthesis of 5-acetamido-5-deoxypentoses. Sugar derivatives containing nitrogen in the ring, J. Org. Chem., 28 (1963) 2604-2610.
21. H. Paulsen, Darstellung von 5-Acetamido-5-deoxy-D-xylopiperidinose, Angew. Chem., 74 (1962) 901.
22. T. J. Adley and L. N. Owen, Thio sugars with sulphur in the ring, Proc. Chem. Soc. (1961) 418.
23. J. C. P. Schwarz and K. C. Yule, D-Xylothiapyranose: A sugar with sulfur in the ring, Proc. Chem. Soc. (1961) 417.
24. M. S. Feather and R. L. Whistler, Derivatives of 5-thio-D-glucose, Tetrahedron Lett., 3 (1962) 667-668.
25. U. G. Nayak and R. L. Whistler, Synthesis of 5-thio-D-glucose, J. Org. Chem., 34 (1969) 97-100.
26. M. Yagi, T. Kouno, Y. Aoyagi, and H. Murai, The structure of moranoline, a piperidine alkaloid from Morus species, Nippon Nogei Kagaku Kaishi, 50 (1976) 571-572.
27. A. Welter, J. Jadot, G. Dardenne, M. Marlier, and J. Casimir, 2,5-Dihydroxymethyl 3,4-dihydroxypyrrolidine dans les feuilles de Derris elliptica, Phytochemistry, 15 (1976) 747-749.
28. L. D. Hohenschutz, E. A. Bell, P. J. Jewess, D. P. Leworthy, R. J. Pryce, E. Arnold, and J. Clardy, Castanospermine, a 1,6,7,8-tetrahydroxyoctahydroindolizine alkaloid, from seeds of Castanospermum australe, Phytochemistry, 20 (1981) 811-814.
29. R. J. Molyneux, M. Benson, R. Y. Wong, J. E. Tropea, and A. D. Elbein, Australine, a novel pyrrolizidine alkaloid glucosidase inhibitor from Castanospermum australe, J. Nat. Prod., 51 (1988) 1198-1206.
30. R. J. Nash, L. E. Fellows, J. V. Dring, G. W. J. Fleet, A. E. Derome, T. A. Hamor, A. M. Scofield, and D. J. Watkin, Isolation from Alexa leiopetala and x-ray crystal structure of alexine, (1R,2R,3R,7S,8S)-3-hydroxymethyl-1,2,7-trihydroxypyrrolizidine [(2R,3R,4R,5S,6S)-2-hydroxymethyl-1-azabicyclo [3.3.0]octan-3,4,6-triol], a unique pyrrolizidine alkaloid, Tetrahedron Lett., 29 (1988) 2487-2490.
31. G. E. McCasland, S. Furuta, and L. J. Durham, Alicyclic carbohydrates. XXIX. The synthesis of a pseudo-hexose (2,3,4,5-tetrahydroxycyclohexanemethanol), J. Org. Chem., 31 (1966) 1516-1521.
32. T. Suami and S. Ogawa, Chemistry of carba-sugars (pseudo-sugars) and their derivatives, Adv. Carbohydr. Chem. Biochem., 48 (1990) 21-90.
33. L. E. Fellows, E. A. Bell, D. G. Lynn, F. Pilkiwicz, I. Miura, and K. Nakanishi, Isolation and structure of an unusual cyclic amino alditol from a legume, J. Chem. Soc., Chem. Commun. (1979) 977-978.
34. H. Paulsen, Y. Hayauchi, and V. Sinnwell, Monosaccharides containing nitrogen in the ring. XXXVII. Synthesis of 1,5-dideoxy-1,5-imino-D-galactitol, Chem. Ber., 113 (1980) 2601-2608.
35. S. M. Colegate, P. R. Dorling, and C. R. Huxtable, A spectroscopic investigation of swainsonine: An α-mannosidase inhibitor isolated from Swainsona canescens, Aust. J. Chem., 32 (1979) 2257-2264.
36. G. Kinast and M. Schedel, Vierstufige 1-Desoxynojirimycin-Synthese mit einer Biotransformation als zentralem Reaktionsschritt, Angew. Chem., 93 (1981) 799-800.
37. K. Leontein, B. Lindberg, and J. Lönngren, Formation of 1,5-dideoxy-1,5-iminohexitols on borohydride reduction of 2-amino-2-deoxyhexofuranurono-6,3-lactones, Acta Chem. Scand. B, 36 (1982) 515-518.
38. U. Fuhrmann, E. Bause, G. Legler, and H. Ploegh, Novel mannosidase inhibitor blocking conversion of high mannose to complex oligosaccharides, Nature, 307 (1984) 755-758.
39. R. J. Nash, E. A. Bell, and J. M. Williams, 2-Hydroxymethyl-3,4-dihydroxypyrrolidine in fruits of Angylocalyx boutiqueanus, Phytochemistry, 24 (1985) 1620-1622.
40. J. Furukawa, S. Okuda, K. Saito, and S. I. Hatanaka, 3,4-Dihydroxy-2-hydroxymethylpyrrolidine from Arachniodes standishii, Phytochemistry, 24 (1985) 593-594.
41. H. Umezawa, T. Aoyagi, T. Komiyama, H. Morishima, M. Hamada, and T. Takeuchi, Purification and characterization of a sialidase inhibitor, siastatin, produced by Streptomyces, J. Antibiot., 27 (1974) 963-969.
42. H. Kayakiri, S. Takase, T. Shibata, M. Okamoto, H. Terano, and M. Hashimoto, Structure of kifunensine, a new immunomodulator isolated from Actinomycete, J. Org. Chem., 54 (1989) 4015-4016.
43. M. Iwami, O. Nakayama, H. Terano, M. Kohsaka, H. Aoki, and H. Imanaka, A new immunomodulator, FR-900494: Taxonomy, fermentation, isolation, and physico-chemical and biological characteristics, J. Antibiot., 40 (1987) 612-622.
44. A. D. Elbein, J. E. Tropea, M. Mitchell, and G. P. Kaushal, Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I, J. Biol. Chem., 265 (1990) 15599-15605.
45. C. M. Harris, T. M. Harris, R. J. Molyneux, J. E. Tropea, and A. D. Elbein, 1-Epiaustraline, a new pyrrolizidine alkaloid from Castanospermum australe, Tetrahedron Lett., 30 (1989) 5685-5688.
46. P.-H. Ducrot and J. L. Lallemand, Structure of the calystegines: New alkaloids of the nortropane family, Tetrahedron Lett., 31 (1990) 3879-3882.
47. M. Shibano, S. Kitagawa, and G. Kusano, Studies on the constituents of Broussonetia species. I. Two new pyrrolidine alkaloids, broussonetines C and D, as β-galactosidase and β-mannosidase inhibitors from Broussonetia kazinoki SIEB., Chem. Pharm. Bull., 45 (1997) 505-508.
48. M. Shibano, S. Kitagawa, S. Nakamura, N. Akazawa, and G. Kusano, Studies on the constituents of Broussonetia species. II. Six new pyrrolidine alkaloids, broussonetine A, B, E, F and broussonetine A and B, as inhibitors of glycosidases, from Broussonetia kazinoki SIEB., Chem. Pharm. Bull., 45 (1997) 700-705.
49. G. W. J. Fleet, P. W. Smith, S. V. Evans, and L. E. Fellows, Design synthesis and preliminary evaluation of a potent α-mannosidase inhibitor: 1,4-Dideoxy-1,4-imino-D-mannitol, J. Chem. Soc., Chem. Commun. (1984) 1240-1241.
50. G. W. J. Fleet, A. N. Shaw, S. V. Evans, and L. E. Fellows, Synthesis from D-glucose of 1,5-dideoxy-1,5-imino-L-fucitol, a potent α-L-fucosidase inhibitor, J. Chem. Soc., Chem. Commun. (1985) 841-842.
51. G. W. J. Fleet, S. J. Nicholas, P. W. Smith, S. V. Evans, L. E. Fellows, and R. J. Nash, Potent competitive inhibition of α-galactosidase and α-glucosidase activity by 1,4-dideoxy-1,4-iminopentitols: Syntheses of 1,4-dideoxy-1,4-imino-D-lyxitol and of both enantiomers of 1,4-dideoxy-1,4-iminoarabinitol, Tetrahedron Lett., 26 (1985) 3127-3130.
52. G. W. J. Fleet, P. W. Smith, R. J. Nash, L. E. Fellows, R. B. Parekh, and T. W. Rademacher, Synthesis of 2-acetamido-1,5-imino-1,2,5-trideoxy-D-mannitol and of 2-acetamido-1,5-imino-1,2,5-trideoxy-D-glucitol, a potent and specific inhibitor of a number of β-N-acetylglucosaminidases, Chem. Lett. (1986) 1051-1054.
53. G. Legler and E. Jülich, Synthesis of 5-amino-5-deoxy-D-mannopyranose and 1,5-dideoxy-1,5-imino-D-mannitol, and inhibition of α-and β-D-mannosidases, Carbohydr. Res., 128 (1984) 61-72.
54. 2 oligosaccharides, Eur. J. Biochem., 157 (1986) 563-570.
55. K. M. Osiecki-Newman, D. Fabbro, T. Dinur, S. Boas, S. Gatt, G. Legler, R. J. Desnick, and G. A. Grabowski, Human acid β-glucosidase: Affinity purification of the normal placental and Gaucher disease splenic enzymes on N-alkyl-deoxynojirimycin-sepharose, Enzyme, 35 (1986) 147-153.
56. A. de Raadt, C. Ekhart, G. Legler, and A. E. Stütz, Iminoalditols as affinity ligands for the purification of glycosidases, in A. E. Stütz, (Ed.), Iminosugars as Glycosidase Inhibitors, Wiley-VCH, Weinheim, New York, 1999, pp. 207-215.
57. Y. Kishi, Natural products synthesis: Palytoxin, Pure Appl. Chem., 61 (1989) 313-324.
58. R. H. Grubbs, S. J. Miller, and G. C. Fu, Ring closing metathesis and related processes in organic synthesis, Acc. Chem. Res., 28 (1995) 446-452.
59. 60: Buckminsterfullerene, Nature, 318 (1985) 162-163.
60. B. L. Stocker, E. M. Dangerfield, A. L. Win-Mason, G. W. Haslett, and M. S. M. Timmer, Recent developments in the synthesis of pyrrolidine-containing iminosugars, Eur. J. Org. Chem. (2010) 1615-1637.
61. B. G. Davis, A silver-lined anniversary of Fleet iminosugars: 1984-2009, from DIM to DRAM to LABNAc, Tetrahedron: Asymmetry, 20 (2009) 652-671.
62. B. G. Winchester, Iminosugars: From botanical curiosities to licensed drugs, Tetrahedron: Asymmetry, 20 (2009) 645-651.
63. N. Asano, Naturally occurring iminosugars and related alkaloids: Structure, activity and applications, in P. Compain and O. R. Martin, (Eds.), Iminosugars: From Synthesis to Therapeutic Applications, Wiley, Chichester, 2007, pp. 7-24.
64. B. La Ferla, L. Cipolla, and F. Nicotra, General strategies for the synthesis of iminosugars and new approaches towards iminosugar libraries, in P. Compain and O. R. Martin, (Eds.), Iminosugars: From Synthesis to Therapeutic Applications, Wiley, Chichester, 2007, pp. 25-61.
65. M. S. J. Simmonds, G. C. Kite, and E. A. Porter, Taxonomic distribution of iminosugars in plants and their biological activities, in A. E. Stütz, (Ed.), Iminosugars as Glycosidase Inhibitors, Wiley-VCH, Weinheim, New York, 1999, pp. 8-30.
66. B. La Ferla and F. Nicotra, Synthetic methods for the preparation of iminosugars, in A. E. Stütz, (Ed.), Iminosugars as Glycosidase Inhibitors, Wiley-VCH, Weinheim, New York, 1999, pp. 68-92.
67. I. Lundt and R. Madsen, Iminosugars as powerful glycosidase inhibitors-Synthetic approaches from aldonolactones, in A. E. Stütz, (Ed.), Iminosugars as Glycosidase Inhibitors, Wiley-VCH, Weinheim, New York, 1999, pp. 93-111.
68. I. Lundt and R. Madsen, Isoiminosugars: Glycosidase inhibitors with nitrogen at the anomeric position, in A. E. Stütz, (Ed.), Iminosugars as Glycosidase Inhibitors, Wiley-VCH, Weinheim, New York, 1999, pp. 112-124.
69. B. W. Matthews, The structure of E. coli β-galactosidase, C. R. Biol., 328 (2005) 549-556.
70. T. Narikawa, H. Shinoyama, and T. Fujii, A β-rutinosidase from Penicillium rugulosum IFO 7242 that is a peculiar flavonoid glycosidase, Biosci. Biotechnol. Biochem., 64 (2009) 1317-1319.
71. V. Patel and A. L. Tappel, Identity of β-glucosidase and β-xylosidase activities in rat liver lysosomes, Biochim. Biophys. Acta Enzymol., 191 (1969) 653-662.
72. R. Kuhn, Über die spezifische Natur und den Wirkmechanismus kohlehydrat- und glykosidspaltender Enzyme (On the specific nature and the mechanism of action of carbohydrate and glycoside cleaving enzymes), Naturwissenschaften, 11 (1923) 732-742.
73. S. Veibel, Enzymatic and acid hydrolysis of glucosides, Kem. Maanedsblad, 20 (1939) 253-258.
74. W. W. Pigman, Classification of carbohydrases, J. Res. Natl. Bur. Stand., 30 (1943) 257-265.
75. W. W. Pigman, Specificity, classification and mechanism of action of the glycosidases, Adv. Enzymol. Relat. Subj. Biochem., 4 (1944) 41-74.
76. F. Shafizadeh and A. Thompson, An evaluation of the factors influencing the hydrolysis of the aldosides, J. Org. Chem., 21 (1956) 1059-1062.
77. D. E. Koshland, Stereochemistry and the mechanism of enzymatic reactions, Biol. Rev., 28 (1953) 416-426.
78. D. E. Koshland and S. S. Stein, Correlation of bond breaking with enzyme specificity. Cleavage point of invertase, J. Biol. Chem., 208 (1954) 139-148.
79. D. E. Koshland, Physical organic approach to enzymatic mechanisms, Trans. N. Y. Acad. Sci., 16 (1954) 110-113.
80. C. C. F. Blake, D. F. König, G. A. Mair, A. C. T. North, D. C. Phillips, and V. R. Sarma, Structure of hen egg-white lysozyme-A three dimensional Fourier synthesis at 2 A resolution, Nature, 206 (1965) 757-761.
81. C. A. Vernon and B. Banks, The enzymatic hydrolysis of glycosides, Biochem. J., 86 (1963) Proc. Biochem. Soc. 7P.
82. C. A. Vernon, Mechanisms of hydrolysis of glycosides and their relevance to enzyme-catalyzed reactions, Proc. R. Soc. Lond. B Biol. Sci., 167 (1967) 389-401.
83. G. Legler, Glycoside hydrolases: Mechanistic information from studies with reversible and irreversible inhibitors, Adv. Carbohydr. Chem. Biochem., 48 (1990) 319-384.
84. J. D. McCarter and S. G. Withers, Mechanisms of enzymatic glycoside hydrolysis, Curr. Opin. Struct. Biol., 4 (1994) 885-892.
85. V. L. Y. Yip and S. G. Withers, Nature's many mechanisms for the degradation of oligosaccharides, Org. Biomol. Chem., 2 (2004) 2707-2713.
86. C. S. Rye and S. G. Withers, Glycosidase mechanisms, Curr. Opin. Chem. Biol., 4 (2000) 573-580.
87. A. White and D. R. Rose, Mechanism of catalysis by retaining β-glycosyl hydrolases, Curr. Opin. Struct. Biol., 7 (1997) 645-651.
88. S. G. Withers, Enzymatic cleavage of glycosides: How does it happen, Pure Appl. Chem., 67 (1995) 1673-1682.
89. A. L. Fink and N. E. Good, Evidence for a glucosyl-enzyme intermediate in the β-glucosidasecatalyzed hydrolysis of p-nitrophenyl-β-D-glucoside, Biochem. Biophys. Res. Commun., 58 (1974) 126-131.
90. D. L. Zechel and S. G. Withers, Glycosidase mechanisms: Anatomy of a finely tuned catalyst, Acc. Chem. Res., 33 (2000) 11-18.
91. E. J. Hehre, A fresh understanding of the stereochemical behaviour of glycosylases: Structural distinction of "inverting" (2-MCO-type) versus "retaining" (1-MCO-type) enzymes, Adv. Carbohydr. Chem. Biochem., 55 (2000) 265-310.
92. C. B. Post and M. Karplus, Does lysozyme follow the lysozyme pathway? An alternative based on dynamics, structural, and stereoelectronic considerations, J. Am. Chem. Soc., 108 (1986) 1317-1319.
93. G. W. J. Fleet, An alternative proposal for the mode of inhibition of glycosidase activity by polyhydroxylated piperidines, pyrrolidines and indolizidines: Implications for the mechanism of action of some glycosidases, Tetrahedron Lett., 26 (1985) 5073-5076.
94. R. W. Franck, The mechanism of β-glycosidases: A reassessment of some seminal papers, Bioorg. Chem., 20 (1992) 77-88.
95. S. Knapp, D. Vocadlo, Z. Gao, B. Kirk, J. Lou, and S. G. Withers, NAG-thiazoline, an N-acetylβ-hexosaminidase inhibitor that implicates acetamido participation, J. Am. Chem. Soc., 118 (1996) 6804-6805.
96. D. Piszkiewicz and T. C. Bruise, Glycoside hydrolysis. I. Acetamido and hydroxyl group catalysis in glycoside hydrolysis, J. Am. Chem. Soc., 89 (1967) 6237-6243.
97. G. Lowe, G. Sheppard, M. L. Sinnott, and A. Williams, Lysozyme-catalysed hydrolysis of some β-aryl di-N-acetylchitobiosides, Biochem. J., 104 (1967) 893-899.
98. http://www.cazy.org/.
99. M. A. Jermyn, The action of the β-glucosidase of Stachybotrys atra p-nitrophenyl quinovoside, Aust. J. Biol. Sci., 16 (1963) 926.
100. G. Legler, Action mechanism of glucosidase-splitting enzymes. II. Isolation and enzymatic properties of two β-glucosidases from Aspergillus wentii, Hoppe Seyler's Zeitschr. Physiol. Chem., 348 (1967) 1359-1366.
101. G. Legler and L. M. O. Osama, Mechanism of action of glycosidase splitting enzymes. IV. Purification and properties of a β-glucosidase from Aspergillus oryzae, Hoppe Seyler's Zeitschr. Physiol. Chem., 349 (1968) 1488-1492.
102. G. Legler, The mechanism of action of glycosidases, Acta Microbiol. Acad. Sci. Hung., 22 (1975) 403-409.
103. D. E. Walker and B. Axelrod, Evidence for a single catalytic site on the "β-Dglucosidase-β-D-galactosidase" of almond emulsin, Arch. Biochem. Biophys., 187 (1978) 102-107.
104. 3 from Aspergillus wentii, Biochim. Biophys. Acta Enzymol., 657 (1981) 321-333.
105. M. N. Namchuk and S. G. Withers, Mechanism of Agrobacterium β-glucosidase: Kinetic studies of the role of noncovalent enzyme/substrate interactions, Biochemistry, 34 (1995) 16194-16202.
106. T. Mega and Y. Matsushima, Energy of binding of Aspergillus oryzae β-glucosidase with the substrate, and the mechanism of its enzymatic action, J. Biochem., 94 (1983) 1637-1647.
107. B. W. Sigurdskjold, B. Duus, and K. Bock, Hydrolysis of substrate analogues catalysed by β-Dglucosidase from Aspergillus niger. Part II: Deoxy and deoxyhalo derivatives of cellobiose, Acta Chem. Scand., 45 (1991) 1032-1041.
108. M. N. Namchuk, J. D. McCarter, A. Becalski, T. Andrews, and S. G. Withers, The role of sugar substituents in glycoside hydrolysis, J. Am. Chem. Soc., 122 (2000) 1270-1277.
109. T. Nishimura and M. Ishihara, Action of fungal β-glucosidase on the mono-O-methylated p-nitrophenyl β-D-glucopyranoside, Holzforschung, 63 (2009) 47-51.
110. K. Bock and K. Adelhorst, Derivatives of methyl β-lactoside as substrates for and inhibitors of β-D-galactosidase from E. coli, Carbohydr. Res., 202 (1990) 131-149.
111. J. D.McCarter, M. J. Adam, and S. G. Withers, Binding energy and catalysis. Fluorinated and deoxygenated glycosides as mechanistic probes of Escherichia coli (lac Z) β-galactosidase, Biochem. J., 286 (1992) 721-727.
112. A. Rivera-Sagredo, F. J. Canada, O. Nieto, J. Jimenez-Barbero, and M. Martin-Lomas, Substrate specificity of small-intestinal lactase: Assessment of the role of the substrate hydroxyl groups, Eur. J. Biochem., 209 (1992) 415-422.
113. K. Bock and H. Pedersen, The substrate specificity of the enzyme amyloglucosidase (AMG). Part I. Deoxy derivatives, Acta Chem. Scand. B, 41 (1987) 617-628.
114. K. Bock and H. Pedersen, The substrate specificity of the enzyme amyloglucosidase (AMG). Part II. 6-Substituted maltose derivatives, Acta Chem. Scand. B, 42 (1988) 75-85.
115. M. R. Sierks, K. Bock, S. Refn, and B. Svensson, Active site similarities of glucose dehydrogenase, glucose oxidase, and glucoamylase probed by deoxygenated substrates, Biochemistry, 31 (1992) 8972-8977.
116. M. R. Sierks and B. Svensson, Energetic and mechanistic studies of glucoamylase using molecular recognition of maltose OH groups coupled with site-directed mutagenesis, Biochemistry, 39 (2000) 8585-8592.
117. R. U. Lemieux, U. Spohr, M. Bach, D. R. Cameron, T. P. Frandsen, B. B. Stoffer, B. Svensson, and M. M. Palcic, Chemical mapping of the active site of the glucoamylase of Aspergillus niger, Can. J. Chem., 74 (1996) 319-335.
118. T. P. Frandsen, B. B. Stoffer, M. M. Palcic, S. Hof, and B. Svensson, Structure and energetics of the glucoamylase-isomaltose transition state complex probed by using modeling and deoxygenated substrates coupled with site-directed mutagenesis, J. Mol. Biol., 263 (1996) 79-89.
119. T. B. Frandsen, F. Lok, E. Mirgorodskaya, P. Roepstorff, and B. Svensson, Purification, enzymatic characterisation and nucleotide sequence of a high-isoelectric-point α-glucosidase from barley malt, Plant Physiol., 123 (2000) 275-286.
120. M. Ogawa, T. Nishio, W. Hakamata, Y. Matsuishi, S. Hoshino, A. Kondo, M. Kitagawa, R. Kawachi, and T. Oku, Substrate hydroxyl groups are involved in the ionization of catalytic carboxyl groups of Aspergillus niger α-glucosidase, J. Appl. Glycosci., 51 (2004) 9-14.
121. W. Hakamata, T. Nishio, and T. Oku, Synthesis of p-nitrophenyl 3- and 6-deoxy-α-D-glucopyranosides and their specificity to rice α-glucosidase, J. Appl. Glycosci., 46 (1999) 459-463.
122. T. Nishio, W. Hakamata, A. Kimura, S. Chiba, A. Takatsuki, R. Kawachi, and T. Oku, Glycon specificity profiling of α-glucosidases using monodeoxy and mono-O-methyl derivatives of p-nitrophenyl α-D-glucopyranoside, Carbohydr. Res., 337 (2002) 629-634.
123. W. Hakamata, M. Muroi, T. Nishio, T. Oku, and A. Takatsuki, Recognition properties of processing α-glucosidase I and α-glucosidase II, J. Carbohydr. Chem., 23 (2004) 27-39.
124. W. Hakamata, T. Nishio, and T. Oku, Hydrolytic activity of α-galactosidases against deoxy derivatives of p-nitrophenyl α-D-galactopyranoside, Carbohydr. Res., 324 (2000) 107-115.
125. K. J. Dean and C. C. Sweeley, Studies on human liver α-galactosidases. III. Partial characterization of carbohydrate-binding specificities, J. Biol. Chem., 254 (1979) 10006-10010.
126. T. Nishio, Y. Miyake, H. Tsujii, W. Hakamata, K. Kadokura, and T. Oku, Hydrolytic activity of α-mannosidase against deoxy derivatives of p-nitrophenyl α-D-mannopyranoside, Biosci. Biotechnol. Biochem., 60 (1996) 2038-2042.
127. T. Chrzaszcz and J. Janicki, "Sistoamylase", a natural inhibitor of amylase, Biochem. Zeitsch, 260 (1933) 354-368.
128. E. Truscheit, W. Frommer, B. Junge, L. Müller, D. D. Schmidt, and W. Wingender, Chemistry and biochemistry of microbial α-glucosidase inhibitors, Angew. Chem. Int. Ed. Engl., 20 (1981) 744-761.
129. J. J. Marshall and C. M. Lauda, Purification and properties of phaseolamin, an inhibitor of α-amylase, from the kidney bean, Phaseolus vulgaris, J. Biol. Chem., 250 (1975) 8030-8037.
130. S. Ueda, Y. Koba, and H. Chaen, Action of amylase inhibitors produced by Streptomyces sp. on some carbohydrate hydrolases and phosphorylases, Carbohydr. Res., 61 (1978) 253-264.
131. S. Murao, A. Goto, Y. Matsui, and K. Ohyama, New proteinous inhibitor (Haim) of animal α-amylase from Streptomyces griseosporeus YM-25, Agric. Biol. Chem., 44 (1980) 1679-1681.
132. K. Yokose, K. Ogawa, Y. Suzuki, I. Umeda, and Y. Suhara, New α-amylase inhibitor, trestatins. II. Structure of trestatins A, B and C, J. Antibiot., 36 (1983) 1166-1175.
133. G. Limberg, I. Lundt, and J. Zavilla, Deoxyiminoalditols from aldonic acids. VI. Preparation of the four stereoisomeric 4-amino-3-hydroxypyrrolidines from bromodeoxytetronic acids. Discovery of a new α-mannosidase inhibitor, Synthesis (1999) 178-183.
134. G.-F. Dai, H.-W. Xu, J.-F. Wang, F.-W. Liu, and H.-M. Liu, Studies on the novel α-glucosidase inhibitory activity and structure-activity relationships for andrographolide analogues, Bioorg. Med. Chem. Lett., 16 (2006) 2710-2713.
135. Atta-ur-Rahman, S. Zareen, M. I. Choudary, M. N. Akhtar, and S. N. Khan, α-Glucosidase inhibitory activity of triterpenoids from Cichorium intybus, J. Nat. Prod., 71 (2008) 910-913.
136. J. D. Wansi, J. Wandji, L. Mbaze Meva'a, A. F. Kamdem Waffo, R. Ranjit, S. N. Khan, A. Asma, C. M. Iqbal, M.-C. Lallemand, F. Tillequin, and Z. Fomum Tanee, α-Glucosidase inhibitory and antioxidant acridone alkaloids from the stem bark of Oriciopsis glaberrima ENGL. (Rutaceae), Chem. Pharm. Bull., 54 (2006) 292-296.
137. 2, new α-glucosidase inhibitors from a marine sponge Penares sp, Tetrahedron, 56 (2000) 8977-8987.
138. J. H. Kim, Y. B. Ryu, N. S. Kang, B. W. Lee, J. S. Heo, I.-Y. Jeong, and K. H. Park, Glycosidase inhibitory flavonoids from Sophora flavescens, Biol. Pharm. Bull., 29 (2006) 302-305.
139. W. D. Seo, J. H. Kim, J. E. Kang, H. W. Ryu, M. J. Curtis-Long, H. S. Lee, M. S. Yang, and K. H. Park, Sulfonamide chalcone as a new class of α-glucosidase inhibitors, Bioorg. Med. Chem. Lett., 15 (2005) 5514-5516.
140. I. Miwa, J. Okuda, T. Horie, and M. Nakayama, Inhibition of intestinal α-glucosidases and sugar absorbtion by flavones, Chem. Pharm. Bull., 34 (1986) 838-844.
141. J. Y. Kim, J. W. Lee, Y. S. Kim, Y. Lee, Y. B. Ryu, S. Kim, H. W. Ryu, M. J. Curtis-Long, K. W. Lee, W. S. Lee, and K. H. Park, A novel competitive class of α-glucosidase inhibitors: (E)-1-Phenyl-3-(4-styrylphenyl)urea derivatives, ChemBioChem, 11 (2010) 2125-2131.
142. Y.-K. Li and L. D. Byers, Inhibition of β-glucosidase by imidazoles, Biochim. Biophys. Acta, 999 (1989) 227-232.
143. R. A. Field, A. H. Haines, E. J. T. Chrystal, and M. C. Luszniak, Histidines, histamines and imidazoles as glycosidase inhibitors, Biochem. J., 274 (1991) 885-889.
144. P. Magdolen and A. Vasella, Monocyclic, substituted imidazoles as glycosidase inhibitors, Helv. Chim. Acta, 88 (2005) 2454-2469.
145. J. L. Goldstein and T. Swain, The inhibition of enzymes by tannins, Phytochemistry, 4 (1965) 185-192.
146. G. H. B. Maegawa, M. Tropak, J. Buttner, T. Stockley, F. Kok, J. T. R. Clarke, and D. J. Mahuran, Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosis, J. Biol. Chem., 282 (2007) 9150-9161.
147. G. H. B. Maegawa, M. B. Tropak, J. D. Buttner, B. A. Rigat, M. Fuller, D. Pandit, L. Tang, G. J. Kornhaber, Y. Hamuro, J. T. R. Clarke, and D. J. Mahuran, Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease, J. Biol. Chem., 284 (2009) 23502-23516.
148. A. D. Abell, M. J. Ratcliffe, and J. Gerrard, Ascorbic acid-based inhibitors of α-amylases, Bioorg. Med. Chem. Lett., 8 (1998) 1703-1706.
149. G. Legler and W. Lotz, Mechanism of action of glycoside-splitting enzymes. VII. Functional groups at the active site of an α-glucosidase from Saccharomyces cerevisiae, Hoppe-Seyler's Z. Physiol. Chem., 354 (1973) 243-254.
150. S. Atsumi, K. Umezawa, H. Iinuma, H. Naganawa, H. Nakamura, Y. Iitaka, and T. Takeuchi, Production, isolation and structure determination of a novel β-glucosidase inhibitor, cyclophellitol, from Phellinus sp, J. Antibiot., 43 (1990) 49-53.
151. S. Atsumi, H. Iinuma, C. Nosaka, and K. Umezawa, Biological activities of cyclophellitol, J. Antibiot., 43 (1990) 1579-1985.
152. J. Marco-Contelles, Cyclohexane epoxides-Chemistry and biochemistry of (+)-cyclophellitol, Eur. J. Chem. (2001) 1607-1618.
153. S. G. Withers and K. Umezawa, Cyclophellitol: A naturally occurring mechanism-based inactivator of β-glucosidases, Biochem. Biophys. Res. Commun., 177 (1991) 532-537.
154. T. M. Gloster, R. Madsen, and G. J. Davies, Structural basis for cyclophellitol inhibition of β-glucosidase, Org. Biomol. Chem., 5 (2007) 444-446.
155. K. Tatsuta, Y. Niwata, K. Umezawa, K. Toshima, and M. Nakata, Syntheses and enzyme inhibiting activities of cyclophellitol analogs, J. Antibiot., 44 (1991) 912-914.
156. M. Nakata, C. Chong, Y. Niwata, K. Toshima, and K. Tatsuta, A family of cyclophellitol analogs: Synthesis and evaluation, J. Antibiot., 46 (1993) 1919-1922.
157. M. K. Tong and B. Ganem, A potent new class of active-site-directed glycosidase inactivators, J. Am. Chem. Soc., 110 (1988) 312-313.
158. M. L. Sinnot and P. J. Smith, Affinity labelling with deaminatively generated carbonium ion. Kinetics and stoicheiometry of the alkylation of methionine-500 of the lacZ β-galactosidase of Escherichia coli by β-D-galactopyranosylmethyl-p-nitrophenyltriazene, Biochem. J., 175 (1978) 525-538.
159. F. Naider, Z. Bohak, and J. Yariv, Reversible alkylation of a methionyl residue near the active site of β-galactosidase, Biochemistry, 11 (1972) 3202-3207.
160. M. L. Shulman, S. D. Shiyan, and A. Y. Khorlin, Specific irreversible inhibition of sweet-almond β-glucosidase by some β-glycopyranosylepoxyalkanes and β-D-glucopyranosyl isothiocyanate, Biochim. Biophys. Acta, 445 (1976) 169-181.
161. B. P. Rempel and S. G. Withers, Covalent inhibitors of glycosidases and their applications in biochemistry and biology, Glycobiology, 18 (2008) 570-586.
162. G. Legler, Glycosidase inhibition by basic sugar analogs and the transition state of enzymatic glycoside hydrolysis, in A. E. Stütz, (Ed.), Iminosugars as Glycosidase Inhibitors, Wiley-VCH, Weinheim, New York, 1999, pp. 31-67.
163. A. Berecibar, C. Grandjean, and A. Siriwardena, Synthesis and biological activity of natural aminocyclitol glycosidase inhibitors: Mannostatins, trehazolin, allosamidines, and their analogues, Chem. Rev., 99 (1999) 779-844.
164. L. Sim, K. Jayakanthan, S. Mohan, R. Nasi, B. D. Johnston, B. M. Pinto, and D. R. Rose, New glucosidase inhibitors from ayurvedic herbal treatment for type 2 diabetes: Structures and inhibition of human intestinal maltase-glucoamylase with compounds from Salacia reticulata, Biochemistry, 49 (2010) 443-451.
165. S. Mohan and B. M. Pinto, Sulfonium-ion glycosidase inhibitors isolated from Salacia species used in traditional medicine, and related compounds, Coll. Czech. Chem. Commun., 74 (2009) 1117-1136.
166. A. Steiner, A. Stütz, and T. Wrodnigg, Sulfur-containing glycomimetics, in B. O. Fraser-Reid, K. Tatsuta, and J. Thiem, (Eds.), Glycoscience Chemistry and Chemical Biology, 2nd ed. Springer, Berlin, 2008, pp. 1999-2020; Part 9.
167. S. G. Withers, M. Namchuk, and R. Mosi, Potent glycosidase inhibitors: Transition state mimics or simply fortuitous binders? in A. E. Stütz (Ed.), Iminosugars as Glycosidase Inhibitors, Wiley-VCH, Weinheim, New York, 1999, pp. 188-206.
168. R. Wolfenden, X. Lu, and G. Young, Spontaneous hydrolysis of glycosides, J. Am. Chem. Soc., 120 (1998) 6814-6815.
169. T. M. Jespersen, W. Dong, T. Skrydstrup, M. R. Sierks, I. Lundt, and M. Bols, Isofagomine, a potent, new glycosidase inhibitor, Angew. Chem. Int. Ed., 33 (1994) 1778-1779.
170. X. Zhu, K. A. Sheth, S. Li, H.-H. Chang, and J.-Q. Fan, Rational design and synthesis of highly potent β-glucocerebrosidase inhibitors, Angew. Chem. Int. Ed., 44 (2005) 7450-7453.
171. N. Panday, Y. Canac, and A. Vasella, Very strong inhibition of glucosidases by C(2)-substituted tetrahydroimidazopyridines, Helv. Chim. Acta, 83 (2000) 58-79.
172. R. Saul, R. J. Molyneux, and A. D. Elbein, Studies on the mechanism of castanospermine inhibition of α-and β-glucosidases, Arch. Biochem. Biophys., 230 (1984) 668-675.
173. J. N. Greul, M. Kleban, B. Schneider, S. Picasso, and V. Jäger, Amino(hydroxymethyl)cyclopentanetriols, an emerging class of potent glycosidase inhibitors-Part II: Synthesis and optimisazion of β-D-galactopyranoside analogues, ChemBioChem, 2 (2001) 368-370.
174. S. Ogawa, M. Ashiura, C. Uchida, S. Watanabe, C. Yamazaki, K. Yamagishi, and J. Inokuchi, Synthesis of potent β-D-glucocerebrosidase inhibitors: N-Alkyl-β-valienamines, Bioorg. Med. Chem. Lett., 6 (1996) 929-932.
175. T. M. Wrodnigg, S. G. Withers, and A. E. Stütz, Novel, lipophilic derivatives of 2,5-dideoxy-2,5-imino-D-mannitol (DMDP) are powerful β-glucosidase inhibitors, Bioorg. Med. Chem. Lett., 11 (2001) 1063-1064.
176. T. Wennekes, R. J. B. H. N. van den Berg, K. M. Bonger, W. E. Donker-Koopman, A. Ghisaidoobe, G. A. van der Marel, A. Strijland, J. M. F. G. Aerts, and H. S. Overkleeft, Synthesis and evaluation of dimeric lipophilic iminosugars as inhibitors of glucosylceramide metabolism, Tetrahedron: Asymmetry, 20 (2009) 836-846.
177. Y. Ichikawa and Y. Igarashi, An extremely potent inhibitor for β-galactosidase, Tetrahedron Lett., 36 (1995) 4585-4586.
178. M1 gangliosidosis affected cell lines, Carbohydr. Res., 346 (2011) 1592-1598.
179. S. Ogawa, Y. K. Matsunaga, and Y. Suzuki, Chemical modification of the β-glucocerebrosidase inhibitor N-octyl-β-valienamine: Synthesis and biological evaluation of 4-epimeric and 4-O-(β-Dgalactopyranosyl) derivatives, Bioorg. Med. Chem., 10 (2002) 1967-1972.
180. V. L. Schramm and P. C. Tyler, Transition state analogue inhibitors of N-ribosyltransferases, in P. Compain and O. R. Martin, (Eds.), Iminosugars: From Synthesis to Therapeutic Applications, Wiley, Chichester, 2007, pp. 177-208.
181. R. V. Stick, The synthesis of novel enzyme inhibitors and their use in defining the active sites of glycan hydrolases, Top. Curr. Chem., 187 (1997) 187-213.
182. P. Bach and M. Bols, Synthesis of an 1-azaglucose analog with ring oxygen retained, Tetrahedron Lett., 40 (1999) 3461-3464.
183. W. M. Best, J. M. MacDonald, B. W. Skelton, R. V. Stick, D. M. G. Tilbrook, and A. H. White, The synthesis of a carbohydrate-like dihydrooxazine and tetrahydrooxazine as putative inhibitors of glycoside hydrolases: A direct synthesis of isofagomine, Can. J. Chem., 80 (2002) 857-865.
184. H. Liu, X. Liang, H. Sohoel, A. Bülow, and M. Bols, Noeuromycin, a glycosyl cation mimic that strongly inhibits glycosidases, J. Am. Chem. Soc., 123 (2001) 5116-5117.
185. 3 of Aspergillus wentii, J. Chem. Soc., Perkin Trans. 2 (1980) 1376-1383.
186. H. H. Jensen and M. Bols, Synthesis of 1-azagalactofagomine, a potent galactosidase inhibitor, J. Chem. Soc., Perkin Trans. 1 (2001) 905-909.
187. a of isofagomines, Angew. Chem. Int. Ed., 40 (2001) 3447-3449.
188. H. H. Jensen, L. Lyngbye, A. Jensen, and M. Bols, Stereoelectronic substituent effects in polyhydroxylated piperidines and hexahydropyridazines, Chem. Eur. J., 8 (2002) 1218-1226.
189. J. P. Snyder, N. S. Chandrakumar, H. Sato, and D. C. Lankin, The unexpected diaxial orientation of cis-3,5-difluoropiperidine in water: A potent CF-NH charge dipole effect, J. Am. Chem. Soc., 122 (2000) 544-545.
190. D. C. Lankin, N. S. Chandrakumar, S. N. Rao, D. P. Spangler, and J. P. Snyder, Protonated 3-fluoropiperidines. An unusual fluoro directing effect and a test for quantitative theories of solvation, J. Am. Chem. Soc., 115 (1993) 3356-3357.
191. M. Bols, X. Liang, and H. H. Jensen, Equatorial contra axial polar substituents. The relation of a chemical reaction to stereochemical substituent constants, J. Org. Chem., 67 (2002) 8970-8974.
192. C. McDonnell, O. Lopez, P. Murphy, J. G. Fernandez Bolanos, R. Hazell, and M. Bols, Conformational effects on glycoside reactivity: Study of the high reactive conformer of glucose, J. Am. Chem. Soc., 126 (2004) 12374-12385.
193. T. D. Heightman and A. T. Vasella, Recent insights into inhibition, structure, and mechanism of configuration-retaining glycosidases, Angew. Chem. Int. Ed., 38 (1999) 750-770.
194. S. Vonhoff, K. Piens, M. Pipelier, C. Braet, M. Claeyssens, and A. Vasella, Inhibition of cellobiohydrolases from Trichoderma reesei. Synthesis and evaluation of some glucose-, cellobiose-, and cellotriose-derived hydroximolactams and imidazoles, Helv. Chim. Acta, 82 (1999) 963-980.
195. A. Varrot, M. Schülein, M. Pipelier, A. Vasella, and G. J. Davies, Lateral protonation of a glycosidase inhibitor. Structure of the Bacillus agaradhaerens Cel5A in complex with cellobiose-derived imidazole at 0.97 Å resolution, J. Am. Chem. Soc., 121 (1999) 2621-2622.
196. T. M. Gloster, S. Roberts, G. Perugino, M. Rossi, M. Moracci, N. Panday, M. Terinek, A. Vasella, and G. J. Davies, Structural, kinetic and thermodynamic analysis of glucoimidazole-derived glycosidase inhibitors, Biochemistry, 45 (2006) 11879-11884.
197. B. Shanmugasundaram and A. Vasella, Synthesis of new C(2)-substituted gluco-configured tetrahydroimidazopyridines and their evaluation as glucosidase inhibitors, Helv. Chim. Acta, 88 (2005) 2593-2602.
198. V. Notenboom, S. J. Williams, R. Hoos, S. G. Withers, and D. R. Rose, Detailed structural analysis of glycosidase/inhibitor interactions: Complexes of Cex from Cellulomonas fimi with xylobiose-derived aza-sugars, Biochemistry, 39 (2000) 11553-11563.
199. S. Williams, R. Hoos, and S. G. Withers, Nanomolar versus millimolar inhibition by xylobiosederived azasugars: Significant differences between structurally distinct xylanases, J. Am. Chem. Soc., 122 (2000) 2223-2235.
200. W. Nerinckx, T. Desmet, K. Piens, and M. Claeyssens, An elaboration on the syn-anti proton donor concept of glycoside hydrolases. Electrostatic stabilisation of the transition state as a general strategy, FEBS Lett., 579 (2005) 302-312.
201. N. K. Vyas, Atomic features of protein-carbohydrate interactions, Curr. Opin. Struct. Biol., 1 (1991) 732-740.
202. T. Collins, D. De Vos, A. Hoyoux, S. N. Savvides, C. Gerday, J. Van Beeumen, and G. Feller, Study of the active site residues of a glycoside hydrolase family 8 xylanase, J. Mol. Biol., 354 (2005) 425-435.
203. C. W. Ekhart, M. H. Fechter, P. Hadwiger, E. Mlaker, A. E. Stütz, A. Tauss, and T. M. Wrodnigg, Tables of glycosidase inhibitors with nitrogen in the sugar ring and their activities, in A. E. Stütz, (Ed.), Iminosugars as Glycosidase Inhibitors, Wiley-VCH, Weinheim, New York, 1999, pp. 254-390.
204. N. Asano, K. Oseki, E. Kaneko, and K. Matsui, Enzymic synthesis of α-and β-D-glucosides of 1-deoxynojirimycin and their glycosidase inhibitory activities, Carbohydr. Res., 258 (1994) 255-266.
205. A. Kato, N. Asano, H. Kizu, and K. Matsui, Fagomine isomers and glycosides from Xanthocercis zambesiaca, J. Nat. Prod., 60 (1997) 312-314.
206. J.-Y. Goujon, D. Gueyrard, P. Compain, O. R. Martin, K. Ikeda, A. Kato, and N. Asano, General synthesis and biological evaluation of α-1-C-substituted derivatives of fagomine (2-deoxynojirimycin-α-C-glycosides), Bioorg. Med. Chem., 13 (2005) 2313-2324.
207. N. Asano, K. Oseki, H. Kizu, and K. Matsui, Nitrogen-in-the-ring pyranoses and furanoses: Structural basis of inhibition of mammalian glycosidases, J. Med. Chem., 37 (1994) 3701-3706.
208. T. Kajimoto, K. K.-C. Liu, R. L. Pederson, Z. Zhong, Y. Ichikawa, J. C. Porco, and C.-H. Wong, Enzyme-catalyzed aldol condensation for asymmetric synthesis of azasugars: Synthesis, evaluation, and modelling of glycosidase inhibitors, J. Am. Chem. Soc., 113 (1991) 6187-6196.
209. G. Legler, unpublished.
210. B. Winchester, S. Al Daher, N. C. Carpenter, I. Cenci di Bello, S. S. Choi, A. J. Fairbanks, and G. W. J. Fleet, The structural basis of the inhibition of human α-mannosidases by azafuranose analogues of mannose, Biochem. J., 290 (1993) 743-749.
211. J. L. Reymond and P. Vogel, Application of new optically pure ketene equivalents derived from tartaric acids to the total, asymmetric syntheses of (+)-6-deoxycastanospermine and (+)-6-deoxy-6-fluorocastanospermine, J. Chem. Soc., Chem. Commun. (1990) 1070-1072.
212. J. L. Reymond, A. A. Pinkerton, and P. Vogel, Total asymmetric synthesis of (+)-castanospermine, (+)-6-deoxycastanospermine, and (+)-6-deoxy-6-fluorocastanospermine, J. Org. Chem., 56 (1991) 2128-2135.
213. C.-K. Lee, K. Y. Sim, and J. Zhu, Enantiomeric synthesis of polyhydroxylated indolizidine analogues related to castanospermine: 1-Deoxy-7-epicastanospermine and 1,7-dideoxy-7-fluorocastanospermine, Tetrahedron, 48 (1992) 8541-8544.
214. R. H. Furneaux, J. M. Mason, and P. C. Tyler, The chemistry of castanospermine. Part II: Synthesis of deoxyfluoro analogues of castanospermine, Tetrahedron Lett., 35 (1994) 3143-3146.
215. R. H. Furneaux, G. J. Gainsford, J. M. Mason, and P. C. Tyler, The chemistry of castanospermine. Part I: Synthetic modifications at C-6, Tetrahedron, 50 (1994) 2131-2160.
216. R. H. Furneaux, G. J. Gainsford, J. M. Mason, P. C. Tyler, O. Hartley, and B. Winchester, The chemistry of castanospermine. Part IV: Synthetic modifications at C-8, Tetrahedron, 51 (1995) 12611-12630.
217. R. H. Furneaux, G. J. Gainsford, J.M. Mason, and P. C. Tyler, The chemistry of castanospermine. Part V: Synthetic modifications at C-1 and C-7, Tetrahedron, 53 (1997) 245-268.
218. K. Dax, V. Grassberger, and A. E. Stütz, Simple synthesis of 1,5,6-trideoxy-1,5-imino-D-glucitol, the first fluorine-containing derivative of glucosidase inhibitor 1-deoxynojirimycin, J. Carbohydr. Chem., 9 (1990) 903-908.
219. J. Di, B. Rajanikanth, and W. A. Szarek, Fluorinated 1,5-dideoxy-1,5-iminoalditols: Synthesis of 1,5,6-trideoxy-6-fluoro-1,5-imino-D-glucitol (1,6-dideoxy-6-fluoronojirimycin) and 1,4,5-trideoxy-4-fluoro-1,5-imino-D-ribitol (1,2,5-trideoxy-2-fluoro-1,5-imino-L-ribitol), J. Chem. Soc., Perkin Trans. 1 (1992) 2151-2152.
220. D. P. Getman and D. P. De Crescenzo, Eur. Pat. Appl. (1991) EP 410953 A2 19910130.
221. G. A. De Crescenzo and D. P. Getman, Eur. Pat. Appl. (1992) EP 481950 A2 19920422.
222. C.-K. Lee, H. Jiang, L. L. Koh, and Y. Xu, Synthesis of 1,3-dideoxy-3-fluoronojirimycin, Carbohydr. Res., 239 (1993) 309-315.
223. C.-K. Lee and H. J. Jiang, Asymmetric synthesis of derivatives of 1-deoxynojirimycin. 3. Asymmetric synthesis of 1,3,6-trideoxy-3,6-difluoronojirimycin, J. Carbohydr. Chem., 14 (1995) 407-416.
224. C.-K. Lee, H. Jiang, A. Linden, and A. Scofield, 1,3,6-Trideoxy-3,6-difluoronojirimycin: Structure and evaluation as a glucosidase inhibitor, Carbohydr. Lett., 1 (1996) 417-423.
225. A. Arnone, P. Bravo, A. Donadelli, and G. Resnati, Fluorinated analogues of nojirimycin and mannojirimycin from a non-carbohydrate precursor, Tetrahedron, 52 (1996) 131-142.
226. M. A. Szarek, X. Wu, and W. A. Szarek, Synthesis and evaluation of 1,5,6-trideoxy-6,6-difluoro-1,5-imino-D-glucitol (1,6-dideoxy-6,6-difluoronojirimycin) as a glucosidase inhibitor, Carbohydr. Res., 299 (1997) 165-170.
227. R.-W. Wang, X.-L. Qiu, M. Bols, F. Ortega-Caballero, and F.-L. Qing, Synthesis and biological evaluation of glycosidase inhibitors: gem-Difluoromethylenated nojirimycin analogues, J. Med. Chem., 49 (2006) 2989-2997.
228. R. Csuk, E. Prell, C. Korb, R. Kluge, and D. Ströhl, Total synthesis of 3,3-difluorinated 1-deoxynojirimycin analogues, Tetrahedron, 66 (2010) 467-472.
229. E. Prell and R. Csuk, Amplification of the inhibitory activity of miglitol by monofluorination, Bioorg. Med. Chem. Lett., 19 (2009) 5673-5674.
230. R. Li, M. Bols, C. Rousseau, X. Zhang, R. Wang, and F.-L. Qing, Synthesis and biological evaluation of potent glycosidase inhibitors: 4-Deoxy-4,4-difluoroisofagomine and analogues, Tetrahedron, 65 (2009) 3717-3727.
231. R. Csuk, E. Prell, S. Reissmann, and C. Korb, First total synthesis of a fluorinated calystegin, Z. Naturforsch., 65b (2009) 445-451.
232. S. M. Andersen, M. Ebner, C. W. Ekhart, G. Gradnig, G. Legler, I. Lundt, A. E. Stütz, S. G. Withers, and T. Wrodnigg, Two isosteric fluorinated derivatives of the powerful glucosidase inhibitors, 1-deoxynojirimycin and 2,5-dideoxy-2,5-imino-D-mannitol: Syntheses and glycosidase inhibitory activities of 1,2,5-trideoxy-2-fluoro-1,5-imino-D-glucitol and of 1,2,5-trideoxy-1-fluoro-2,5-imino-D-mannitol, Carbohydr. Res., 301 (1997) 155-166.
233. Y.-X. Li, M.-H. Huang, Y. Yamashita, A. Kato, Y.-M. Jia, W.-B. Wang, G. W. J. Fleet, R. J. Nash, and C.-Y. Yu, L-DMDP, L-homoDMDP ad their C-3 fluorinated derivatives: Synthesis and glycosidase inhibition, Org. Biomol. Chem., 9 (2011) 3405-3414.
234. R.-W. Wang, J. Xu, O. Lopez, M. Bols, and F.-L. Qing, Difluoromethylenated polyhydroxylated pyrrolidines: Facile synthesis, crystal structure and biological evaluation, Future Med. Chem., 1 (2009) 991-997.
235. P. C. Tyler and B. G. Winchester, Synthesis and biological activity of castanospermine and close analogs, in A. E. Stütz, (Ed.), Iminosugars as Glycosidase Inhibitors, Wiley-VCH, Weinheim, New York, 1999, pp. 125-156.
236. A. Hentges and E. Bause, Affinity purification and characterization of glucosidase II from pig liver, Biol. Chem., 378 (1997) 1031-1038.
237. A. Lewandowicz, E. A. Taylor Ringia, L.-M. Ting, K. Kim, P. C. Tyler, G. B. Evans, O. V. Zubkova, S. Mee, G. F. Painter, D. H. Lenz, R. H. Furneaux, and V. L. Schramm, Energetic mapping of transition state analogue interactions with human and Plasmodium falciparum purine nucleoside phosphorylase, J. Biol. Chem., 280 (2005) 30320-30328.
238. G. B. Evans, R. H. Furneaux, A. Lewandowicz, V. L. Schramm, and P. C. Tyler, Exploring structureactivity relationships of transition state analogues of human purine nucleoside phosphorylase, J. Med. Chem., 46 (2003) 3412-3423.
239. J. M. Mason, A. S. Murkin, L. Li, V. L. Schramm, G. J. Gainsford, and B. W. Skelton, A β-fluoroamine inhibitor of purine nucleoside phosphorylase, J. Med. Chem., 51 (2008) 5880-5884.
240. A. A. Edwards, J. M. Mason, K. Clinch, P. C. Tyler, G. B. Evans, and V. L. Schramm, Altered enthalpy-entropy compensation in picomolar transition state analogues of human nucleoside phosphorylase, Biochemistry, 48 (2009) 5226-5238.
241. A. E. Stütz, Some reflections on structure-activity relationships in glycosidase-inhibiting iminoalditols and iminosugars, in A. E. Stütz, (Ed.), Iminosugars as Glycosidase Inhibitors, Wiley-VCH, Weinheim, New York, 1999, pp. 157-187.
242. S. Ravaud, X. Robert, H. Watzlawick, R. Haser, R. Mattes, and N. Aghajari, Trehalulose synthase native and carbohydrate complexed structures provide insights into sucrose isomerisation, J. Biol. Chem., 282 (2007) 28126-28136.
243. http://www.pdb.org/pdb/home/home.do.
244. K. Karaveg, A. Siriwardena, W. Tempel, Z.-J. Liu, J. Glushka, B.-C. Wang, and K. W. Moremen, Mechanism of class 1 (glycosylhydrolase family 47) α-mannosidases involved in N-glycan processing and endoplasmatic reticulum quality control, J. Biol. Chem., 280 (2005) 16197-16207.
245. C. A. Collyer, J. D. Goldberg, H. Viehmann, D. M. Blow, N. G. Ramsden, G. W. J. Fleet, F. J. Montgomery, and P. Grice, Anomeric specificity of D-xylose isomerase, Biochemistry, 31 (1992) 12211-12218.
246. E. M. S. Harris, A. E. Aleshin, L. M. Firsov, and R. B. Honzatko, Refined structure of the complex of 1-deoxynojirimycin with glucoamylase from Aspergillus awamori var. X100 to 2.4-Å resolution, Biochemistry, 32 (1993) 1618-1626.
247. A. Hempel, N. Camerman, D. Mastropaolo, and A. Camerman, Glucosidase inhibitors: Structures of deoxynojirimycin and castanospermine, J. Med. Chem., 36 (1993) 4082-4086.
248. R. Kanai, K. Haga, K. Yamane, and K. Harata, Crystal structure of cyclodextrin glucanotransferase from alkalophilic Bacillus sp. 1011 complexed with 1-deoxynojirimycin at 2.0 Å resolution, J. Biochem., 129 (2001) 593-598.
249. D. L. Zechel, A. B. Boraston, T. Gloster, C. M. Boraston, J. M. Macdonald, D. M. G. Tilbrook, R. V. Stick, and G. J. Davies, Iminosugar glycosidase inhibitors: Structural and thermodynamic dissection of the binding of isofagomine and 1-deoxynojirimycin to β-glucosidases, J. Am. Chem. Soc., 125 (2003) 14313-14323.
250. A. Varrot, C. A. Tarling, J. M. Macdonald, R. V. Stick, D. L. Zechel, S. G. Withers, and G. J. Davies, Direct observation of the protonation state of an iminosugar glycosidase inhibitor upon binding, J. Am. Chem. Soc., 125 (2003) 7496-7497.
251. T. M. Gloster, J. M. Macdonald, C. A. Tarling, R. V. Stick, S. G. Withers, and G. J. Davies, Structural, thermodynamic, and kinetic analyses of tetrahydrooxazine-derived inhibitors bound to β-glucosidases, J. Biol. Chem., 279 (2004) 49236-49242.
252. T. M. Gloster, S. J. Williams, S. Roberts, C. A. Tarling, J. Wicki, S. G. Withers, and G. J. Davies, Atomic resolution analyses of the binding of xylobiose-derived deoxynojirimycin and isofagomine to xylanase Xyn10A, Chem. Commun. (2004) 1794-1795.
253. T. Gloster, S. J. Williams, C. A. Tarling, S. Roberts, C. Dupont, P. Jodoin, F. Shareck, S. G. Withers, and G. J. Davies, A xylobiose-derived isofagomine lactam glycosidase inhibitor binds as its amide tautomer, Chem. Commun. (2003) 944-945.
254. V. H. Lillelund, H. Z. Liu, X.-F. Liang, H. Sohoel, and M. Bols, Isofagomine lactams, synthesis and enzyme inhibition, Org. Biomol. Chem., 1 (2003) 282-287.
255. F. Vincent, T. M. Gloster, J. Macdonald, C. Moorland, R. V. Stick, F. M. V. Dias, J. A. M. Prates, C. M. G. A. Fontes, H. J. Gilbert, and G. J. Davies, Common inhibition of both β-glucosidases and β-mannosidases by isofagomine lactam reflects different conformational itineraries for pyranoside hydrolysis, ChemBioChem, 5 (2004) 1596-1599.
256. A. Varrot, J. Macdonald, R. V. Stick, G. Pell, H. J. Gilbert, and G. J. Davies, Distortion of a cellobioderived isofagomine highlights the potential conformational itinerary of inverting β-glucosidases, Chem. Commun. (2003) 946-947.
257. A. Varrot, S. Leydier, G. Pell, J. M. Macdonald, R. V. Stick, B. Henrissat, H. J. Gilbert, and G. J. Davies, Mycobacterium tuberculosis strains possess functional cellulases, J. Biol. Chem., 280 (2005) 20181-20184.
258. M. E. C. Caines, S. M. Hancock, C. A. Tarling, T. M. Wrodnigg, R. V. Stick, A. E. Stütz, A. Vasella, S. G. Withers, and N. C. J. Strynadka, The structural basis of glycosidase inhibition by five-membered iminocyclitols: The clan A glycoside hydrolase endoglycoceramidase as a model system, Angew. Chem. Int. Ed., 46 (2007) 4474-4476.
259. T. M. Gloster, S. Roberts, V. M-A Ducros, G. Perugino, M. Rossi, R. Hoos, M. Moracci, A Vasella, and G. J. Davies, Structural studies of the β-glucosidase from Sulfolobus solfataricus in complex with covalently and noncovalently bound inhibitors, Biochemistry, 43 (2004) 6101-6109.
260. A. Frankowski, C. Seliga, and J. Streith, Imidazole analogues of 6-epicastanospermine and of 3,7a-diepialexine, Helv. Chim. Acta, 74 (1991) 934-940.
261. K. Tatsuta, S. Miura, S. Ohta, and H. Gunji, Total syntheses of de-branched nagstatin and its analogs having glycosidase inhibiting activities, Tetrahedron Lett., 36 (1995) 1085-1088.
262. T. Granier and A. Vasella, Synthesis and evaluation as glycosidase inhibitors of 1H-imidazol-2-yl C-glycopyranosides, Helv. Chim. Acta, 78 (1995) 1738-1746.
263. T. Granier, N. Panday, and A. Vasella, Structure-activity relations of imidazo-pyridine-type inhibitors of β-D-glucosidases, Helv. Chim. Acta, 80 (1997) 979-987.
264. M. Hrmova, R. de Gori, B. J. Smith, A. Vasella, J. N. Varghese, and G. B. Fincher, Three-dimensional structure of the barley β-D-glucan glucohydrolase in complex with a transition state mimic, J. Biol. Chem., 279 (2004) 4970-4980.
265. M. Hrmova, V. A. Streltsov, B. J. Smith, A. Vasella, J. N. Varghese, and G. B. Fincher, Structural rationale for low-nanomolar binding of transitition state mimics to a family GH3 β-D-glucan glucohydrolase from barley, Biochemistry, 44 (2005) 16529-16539.
266. T. M. Gloster, P. Meloncelli, R. V. Stick, D. Zechel, A. Vasella, and G. J. Davies, Glycosidase inhibition: An assessment of the binding of 18 putative transition-state mimics, J. Am. Chem. Soc., 129 (2007) 2345-2354.
267. L. Verdoucq, J. Moriniere, D. R. Bevan, A. Esen, A. Vasella, B. Henrissat, and M. Czjzek, Structural determinants of substrate specificity in family 1 β-glucosidases, J. Biol. Chem., 279 (2004) 31796-31803.
268. W. P. Burmeister, S. Cottaz, P. Rollin, A. Vasella, and B. Henrissat, High resolution X-ray crystallography shows that ascorbate is a cofactor for myrosinase and substitutes for the function of the catalytic base, J. Biol. Chem., 275 (2000) 39385-39393.
269. B. Brumshtein, H. M. Greenblatt, T. D. Butters, Y. Shaaltiel, D. Aviezer, I. Silman, A. H. Futerman, and J. L. Sussman, Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid β-glucosidase. Insights into the mechanism of chemical chaperone action in Gaucher disease, J. Biol. Chem., 282 (2007) 29052-29058.
270. L. Premkumar, A. R. Sawkar, S. Boldin-Adamsky, L. Toker, I. Silman, J. W. Kelly, A. H. Futerman, and J. L. Sussman, X-ray structure of human acid-β-glucosidase covalently bound to conduritol-B-epoxide, J. Biol. Chem., 25 (2005) 23815-23819.
271. R. L. Lieberman, B. A. Wustman, P. Huertas, A. C. Powe, Jr., C. W. Pine, R. Khanna, M. G. Schlossmacher, D. Ringe, and G. A. Petsko, Structure of acid β-glucosidase with pharmacological chaperone provides insight into Gaucher disease, Nat. Chem. Biol., 3 (2007) 101-107.
272. R. L. Lieberman, J. A. D'aquino, D. Ringe, and G. A. Petsko, Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability, Biochemistry, 48 (2009) 4816-4827.
273. S. M. Cutfield, G. J. Davies, G. Murshudov, B. F. Anderson, P. C. E. Moody, P. A. Sullivan, and J. F. Cutfield, The structure of the exo-β-(1,3)-glucanase from Candida albicans in native and bound forms: Relationship between a pocket and groove in family 5 glycosyl hydrolases, J. Mol. Biol., 294 (1999) 771-783.
274. T. Jank, M. O. P. Ziegler, G. E. Schulz, and K. Aktories, Inhibition of the glucosyltransferase activity of clostridial Rho/Ras-glucosylating toxins by castanospermine, FEBS Lett., 582 (2008) 2277-2288.
275. M. Aguilar-Moncayo, T. M. Gloster, J. P. Turkenburg, M. I. Garcia-Moreno, C. Ortiz Mellet, G. J. Davies, and J. M. Garcia Fernandez, Glycosidase inhibition by ring modified castanospermine analogues: Tackling enzyme selectivity by inhibitor tailoring, Org. Biomol. Chem., 7 (2009) 2738-2747.
276. B. Brumshtein, M. Aguilar-Moncayo, M. I. Garcia-Moreno, C. Ortiz Mellet, J. M. Garcia Fernandez, I. Silman, Y. Shaaltiel, D. Aviezer, J. L. Sussman, and A. H. Futerman, 6-Amino-6-deoxy-5,6-di-N-(N'-octyliminomethylidene)nojirimycin: Synthesis, biological evaluation, and crystal structure in complex with acid β-glucosidase, ChemBioChem, 10 (2009) 1480-1485.
277. T. M. Gloster, J. P. Turkenburg, J. R. Potts, B. Henrissat, and G. J. Davies, Divergence of catalytic mechanism within a glycosidase family provides insight into evolution of carbohydrate metabolism by human gut flora, Chem. Biol., 15 (2008) 1058-1067.
278. S. Ravaud, X. Robert, H. Watzlawick, R. Haser, R. Mattes, and N. Aghajari, Structural determinants of product specificity of sucrose isomerases, FEBS Lett., 583 (2009) 1964-1968.
279. T. M. Gloster, R. Madsen, and G. J. Davies, Dissection of conformationally restricted inhibitors binding to a β-glucosidase, ChemBioChem, 7 (2006) 738-742.
280. M. Aguilar, T. M. Gloster, M. I. Garcia-Moreno, C. Ortiz Mellet, G. J. Davies, A. Llebaria, J. Casas, M. Egido-Gabas, and J. M. Garcia Fernandez, Molecular basis for β-glucosidase inhibition by ring-modified calystegine analogues, ChemBioChem, 9 (2008) 2612-2618.
281. A. Herscovics, Importance of glycosidases in mammalian glycoprotein biosynthesis, Biochim. Biophys. Acta, 1473 (1999) 96-107.
282. F. Vallee, K. Karaveg, A. Herscovics, K. W. Moremen, and P. L. Howell, Structural basis for catalysis and inhibition of N-glycan processing class I α-1,2-mannosidases, J. Biol. Chem., 275 (2000) 41287-41298.
283. Y. D. Lobsanov, F. Vallee, A. Imberty, T. Yoshida, P. Yip, A. Herscovics, and P. L. Howell, Structure of Penicillium citrinum α1,2-mannosidase reveals the basis for differences in specificity of the endoplasmatic reticulum and golgi class I enzymes, J. Biol. Chem., 277 (2002) 5620-5630.
284. J. M. H. van den Elsen, D. A. Kuntz, and D. R. Rose, Structure of golgi α-mannosidase II: Target for inhibition of growth and metastasis of cancer cells, EMBO J., 20 (2001) 3008-3017.
285. P. E. Goss, M. A. Baker, J. P. Carver, and J. W. Dennis, Inhibitors of carbohydrate processing: A new class of anticancer agents, Clin. Cancer Res., 1 (1995) 935-944.
286. N. Shah, D. G. Kuntz, and D. R. Rose, Comparison of kifunensine and 1-deoxymannojirimycin binding to class I and II α-mannosidases demonstrates different distortions in inverting and retaining catalytic mechanisms, Biochemistry, 42 (2003) 13812-13816.
287. S. P. Kawatkar, D. A. Kuntz, R. J. Woods, D. R. Rose, and G.-J. Boons, Structural basis of the inhibition of golgi α-mannosidase II by mannostatin A and the role of the thiomethyl moiety in ligandprotein interactions, J. Am. Chem. Soc., 128 (2006) 8310-8319.
288. D. A. Kuntz, W. Zhong, J. Guo, D. R. Rose, and G.-J. Boons, The molecular basis of inhibition of golgi α-mannosidase II by mannostatin A, ChemBioChem, 10 (2009) 268-277.
289. W. Zhong, D. A. Kuntz, B. Ember, H. Singh, K. W. Moremen, D. R. Rose, and G.-J. Boons, Probing the substrate specificity of golgi α-mannosidase II by use of synthetic oligosaccharides and a catalytic nucleophile mutant, J. Am. Chem. Soc., 130 (2008) 8975-8983.
290. D. A. Kuntz, C. A. Tarling, S. G. Withers, and D. R. Rose, Structural analysis of golgi α-mannosidase II inhibitors identified from a focused glycosidase inhibitor screen, Biochemistry, 47 (2008) 10058-10068.
291. L. E. Tailford, W. A. Offen, N. L. Smith, C. Dumon, C. Morland, J. Gratien, M.-P. Heck, R. V. Stick, Y. Bleriot, A. Vasella, H. J. Gilbert, and G. J. Davies, Structural and biochemical evidence for a boat-like transition state in β-mannosidases, Nat. Chem. Biol., 4 (2008) 306-312.
292. D. A. Kuntz, S. Nakayama, K. Shea, H. Hori, Y. Uto, H. Nagasawa, and D. R. Rose, Structural investigation of the binding of 5-substituted swainsonine analogues to golgi α-mannosidase II, ChemBioChem, 11 (2010) 673-680.
293. H. Fiaux, D. A. Kuntz, D. Hoffman, R. C. Janzer, S. Gerber-Lemaire, D. R. Rose, and L. Juillerat-Jeanneret, Functionalised pyrrolidine inhibitors of human type II α-mannosidases as anti-cancer agents: Optimizing the fit for the active site, Bioorg. Med. Chem., 16 (2008) 7337-7346.
294. M. D. L. Suits, Y. Zhu, E. J. Taylor, J. Walton, D. L. Zechel, H. J. Gilbert, and G. J. Davies, Structure and kinetic investigation of Streptococcus pyogenes family GH38 α-mannosidase, PLoS One, 5 (2010) e9006.
295. 2+-dependent family of α-mannosidases in a human gut symbiont, Nat. Chem. Biol., 6 (2010) 125-132.
296. K. J. Gregg, W. F. Zandenberg, J.-H. Hehemann, G. E. Whitworth, L. Deng, D. J. Vocadlo, and A. B. Boraston, Analysis of a new family of widely distributed metal-independent α-mannosidases provides unique insight into the processing of N-linked glycans, J. Biol. Chem., 286 (2011) 15586-15596.
297. A. I. Guce, N. E. Clark, E. N. Salgado, D. R. Ivanen, A. A. Kulminskaya, H. Brumer, III,, and S. C. Garman, Catalytic mechanism of human α-galactosidase, J. Biol. Chem., 285 (2010) 3625-3632.
298. B. L. Mark, D. J. Vocadlo, D. Zhao, S. Knapp, S. G. Withers, and M. N. G. James, Biochemical and structural assessment of the 1-N-azasugar galNAc-isofagomine as a potent family 20 β-N-acetylhexosaminidase inhibitor, J. Biol. Chem., 276 (2001) 42131-42137.
299. B. L. Mark, D. J. Vocadlo, S. Knapp, B. L. Triggs-Raine, S. G. Withers, and M. N. G. James, Crystallographic evidence for substrate-assisted catalysis in a bacterial β-hexosaminidase, J. Biol. Chem., 276 (2001) 10330-10337.
300. B. L. Mark, D. J. Mahuran, M. M. Cherney, D. Zhao, S. Knapp, and M. N. G. James, Crystal structure of human β-hexosaminidase B: Understanding the molecular basis of Sandhoff and Tay-Sachs disease, J. Mol. Biol., 327 (2003) 1093-1109.
301. C. Martinez-Fleites, Y. He, and G. J. Davies, Structural analyses of enzymes involved in the OGlcNAc modification, Biochim. Biophys. Acta, 1800 (2010) 122-133.
302. G. J. Davies and C. Martinez-Fleites, The O-GlcNAc modification: Three-dimentional structure, enzymology and the development of selective inhibitors to probe disease, Biochem. Soc. Trans., 38 (2010) 1179-1188.
303. B. Shanmugasundaram, A. W. Debowski, R. J. Dennis, G. J. Davies, D. J. Vocatlo, and A. Vasella, Inhibition of O-GlcNAcase by a gluco-configured nagstatin and a PUGNAc-imidazole hybrid inhibitor, Chem. Commun. (2006) 4372-4374.
304. H. C. Dorfmueller, V. S. Borodkin, M. Schimpl, S. M. Shepherd, N. A. Shpiro, and D. M. F. van Aalten, GlcNAcstatin: A picomolar, selective O-glcNAcase inhibitor that modulates intracellular O-glcNAcylation levels, J. Am. Chem. Soc., 128 (2006) 16484-16485.
305. A. Scaffidi, K. A. Stubbs, R. J. Dennis, E. J. Taylor, G. J. Davies, D. J. Vocadlo, and R. V. Stick, A 1-acetamido derivative of 6-epi-valienamine: An inhibitor of a diverse group of β-N-acetylglucosaminidases, Org. Biomol. Chem., 5 (2007) 3013-3019.
306. H. C. Dorfmueller, V. S. Borodkin, M. Schimpl, and D. M. F. van Aalten, GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation, Biochem. J., 420 (2009) 221-227.
307. H. C. Dorfmueller, V. S. Borodkin, M. Schimpl, X. Zheng, R. Kime, K. D. Read, and D. M. F. van Aalten, Cell-penetrant, nanomolar O-GlcNAcase inhibitors selective against lysosomal hexosaminidases, Chem. Biol., 17 (2010) 1250-1255.
308. Y. He, A. K. Bubb, K. A. Stubbs, T. M. Gloster, and G. J. Davies, Inhibition of a bacterial O-glcNAcase homologue by lactone and lactam derivatives: Structural, kinetic and thermodynamic analyses, Amino Acids, 40 (2011) 829-839.
309. B. Pluvinage, M. G. Ghinet, R. Brzezinski, A. D. Boraston, and K. A. Stubbs, Inhibition of the exo-β-D-glucosaminidase CsxA by a glucosamine-configured castanospermine and an amino-australine analogue, Org. Biomol. Chem., 7 (2009) 4169-4172.
310. M. S. Macauley, Y. He, T. M. Gloster, K. A. Stubbs, G. J. Davies, and D. J. Vocadlo, Inhibition of O-GlcNAcase using a potent and cell-permeable inhibitor does not induce insulin resistance in 3T3-L1 adipocytes, Chem. Biol., 17 (2010) 937-948.
311. J. Saha and M. W. Peczuh, Synthesis and properties of septanose carbohydrates, Adv. Carbohydr. Chem. Biochem., 66 (2011) 121-186.
312. F. Marcelo, Y. He, S. A. Yuzwa, L. Nieto, J. Jimenez-Barbero, M. Sollogoup, D. J. Vocadlo, G. D. Davies, and Y. Bleriot, Molecular basis for inhibition of GH84 glycoside hydrolases by substituted azepanes: Conformational flexibility enables probing of substrate distortion, J. Am. Chem. Soc., 131 (2009) 5390-5392.
313. i values in the micro- to picomolar range, Angew. Chem. Int. Ed., 49 (2010) 337-340.
314. A. Lammerts van Bueren, S. D. Popat, C.-H. Lin, and G. J. Davies, Structural and thermodynamic analyses of α-L-fucosidase inhibitors, ChemBioChem, 11 (2010) 1971-1974.
315. A. Lammerts van Bueren, A. Ardevol, J. Fayers-Kerr, B. Luo, Y. Zhang, M. Sollogoub, Y. Bleriot, C. Rovira, and G. J. Davies, Analysis of the reaction coordinate of α-L-fucosidases: A combined structural and quantum mechanical approach, J. Am. Chem. Soc., 132 (2010) 1804-1806.
316. M. Nagae, A. Tsuchiya, T. Katayama, K. Yamamoto, S. Wakatsuki, and R. Kato, Structural basis of the catalytic reaction mechanism of novel 1,2-α-L-fucosidase from Bifidobacterium bifidum, J. Biol. Chem., 282 (2007) 18497-18509.
317. N. G. Oikonomakos, C. Tiraidis, D. D. Leonidas, S. E. Zographos, M. Kristiansen, C. U. Jessen, L. Nørskov-Lauritsen, and L. Agius, Iminosugars as potential inhibitors of glycogenolysis: Structural insights into the molecular basis of glycogen phosphorylase inhibition, J. Med. Chem., 49 (2006) 5687-5701.
318. D. A. Kuntz, A. Ghavami, B. D. Johnston, B. M. Pinto, and D. R. Rose, Crystallographic analysis of the interactions of Drosophila melanogaster golgi α-mannosidase II with the naturally occurring glycomimetic salacinol and its analogues, Tetrahedron: Asymmetry, 16 (2005) 25-32.
319. M. Verhaest, W. Lammens, K. Le Roy, C. J. De Ranter, A. Van Laere, A. Rabijns, and W. Van den Ende, Insights into the fine architecture of the active site of chicory fructan 1-exohydrolase: 1-Kestose as substrate vs sucrose as inhibitor, New Phytol., 174 (2007) 90-100.
320. F. Cardona, C. Parmeggiani, E. Faggi, C. Bonaccini, P. Gratteri, L. Sim, T. M. Gloster, S. Roberts, G. J. Davies, D. R. Rose, and A. Goti, Total syntheses of casuarine and its 6-O-α-glucoside: Complementary inhibition towards glycoside hydroalses of the GH31 and GH37 families, Chem. Eur. J., 15 (2009) 1627-1636.
321. F. Cardona, A. Goti, C. Parmeggiani, P. Parenti, M. Forcella, P. Fusi, L. Cipolla, S. M. Roberts, G. J. Davies, and T. M. Gloster, Casuarine-6-O-α-D-glucoside and its analogues are tight binding inhibitors of insect and bacterial trehalases, Chem. Commun., 46 (2010) 2629-2631.
322. M. Degano, S. C. Almo, J. C. Sacchettini, and V. L. Schramm, Trypanosomal nucleoside hydrolase. A novel mechanism from the structure with a transition-state inhibitor, Biochemistry, 37 (1998) 6277-6285.
323. W. Shi, C. M. Li, P. C. Tyler, R. H. Furneaux, C. Grubmeyer, V. L. Schramm, and S. C. Almo, The 2.0 Å structure of human hypoxanthine-guanine phosphoribosyltransferase in complex with a transitionstate analog inhibitor, Nat. Struct. Biol., 6 (1999) 588-593.
324. W. Shi, C. M. Li, P. C. Tyler, R. H. Furneaux, S. M. Cahill, M. E. Girvin, C. Grubmeyer, V. L. Schramm, and S. C. Almo, The 2.0 Å structure of malarial purine phosphoribosyltransferase in complex with a transition-state analogue inhibitor, Biochemistry, 38 (1999) 9872-9880.
325. W. Shi, N. R. Munagala, C. C. Wang, C. M. Li, P. C. Tyler, R. H. Furneaux, C. Grubmeyer, V. L. Schramm, and S. C. Almo, Crystal structures of Giardia lamblia guanidine phosphoribosyltransferase at 1.75 Å, Biochemistry, 39 (2000) 6781-6790.
326. W. Shi, L. A. Basso, D. S. Santos, P. C. Tyler, R. H. Furneaux, J. S. Blanchard, S. C. Almo, and V. L. Schramm, Structures of purine nucleoside phophorylase from Mycobacterium tuberculosis in complexes with immucillin-H and its pieces, Biochemistry, 40 (2001) 8204-8215.
327. G. A. Kicska, P. C. Tyler, G. B. Evans, R. H. Furneaux, W. Shi, A. Fedorov, A. Lewandowicz, S. M. Cahill, S. C. Almo, and V. L. Schramm, Atomic dissection of the hydrogen bond network for transition-state analogue binding to purine nucleoside phosphorylase, Biochemistry, 41 (2002) 14489-14498.
328. W. Filgueira de Azevedo, Jr., F. Canduri, D. Marangoni dos Santos, J. H. Pereira, M. V. B. Dias, R. G. Silva, M. A. Mendes, L. A. Basso, M. S. Palma, and D. S. Santos, Structural basis for inhibition of human PNP by immucillin-H, Biochem. Biophys. Res. Commun., 309 (2003) 917-922.
329. A. Lewandowicz, W. Shi, G. B. Evans, P. C. Tyler, R. H. Furneaux, L. A. Basso, D. S. Santos, S. C. Almo, and V. L. Schramm, Over-the barrier transition state analogues and crystal structure with Mycobacterium tuberculosis purine nucleoside phosphorylase, Biochemistry, 42 (2003) 6057-6066.
330. V. Singh, W. Shi, G. B. Evans, P. C. Tyler, R. H. Furneaux, S. C. Almo, and V. L. Schramm, Picomolar transition state analogue inhibitors of human 5'-methylthioadenosine phosphorylase and X-ray structure with MT-immucillin-A, Biochemistry, 43 (2004) 9-18.
331. W. Shi, L.-M. Ting, G. A. Kicska, A. Lewandowicz, P. C. Tyler, G. B. Evans, R. H. Furneaux, K. Kim, S. C. Almo, and V. L. Schramm, Plasmodium falciparum purine nucleoside phosphorylase. Crystal structures, immucillin inhibitors, and dual catalytic function, J. Biol. Chem., 279 (2004) 18103-18106.
332. W. Versées, J. Barlow, and J. Steyaert, Transition-state complex of the purine-specific nucleoside hydroalse of Trypanosoma vivax: Enzyme conformational changes and implications on catalysis, J. Mol. Biol., 359 (2006) 331-346.
333. A. Vandemeulebroucke, S. de Vos, E. Van Holsbeke, J. Steyaert, and W. Versées, A flexible loop as a functional element in the catalytic mechanism of nucleoside hydrolase from Trypanosoma vivax, J. Biol. Chem., 283 (2008) 22272-22282.
334. A. S. Murkin, M. R. Birck, A. Rinaldo-Matthis, W. Shi, E. A. Taylor, S. C. Almo, and V. L. Schramm, Neighboring group participation in the transition state of human purine nucleoside phosphorylase, Biochemistry, 46 (2007) 5038-5049.
335. E. A. Taylor, A. Rinaldo-Matthis, L. Li, M. Ghanem, K. Z. Hazleton, M. B. Cassera, S. C. Almo, and V. L. Schramm, Anopheles gambiae purine nucleoside phosphorylase: Catalysis, structure, and inhibition, Biochemistry, 46 (2007) 12405-12415.
336. A. Rinaldo-Matthis, C. Wing, M. Ghanem, H. Deng, P. Wu, A. Gupta, P. C. Tyler, G. B. Evans, R. H. Furneaux, S. C. Almo, C. C. Wang, and V. L. Schramm, Inhibition and structure of Trichomonas vaginalis purine nucleoside phosphorylase with picomolar transition state analogues, Biochemistry, 46 (2007) 659-668.
337. A. Rinaldo-Matthis, A. S. Murkin, U. A. Ramagopal, K. Clinch, S. P. H. Mee, G. B. Evans, P. C. Tyler, R. H. Furneaux, S. C. Almo, and V. L. Schramm, L-Enantiomers of transition state analogue inhibitors bound to human purine nucleoside phosphorylase, J. Am. Chem. Soc., 130 (2008) 842-844.
338. A. Fornili, B. Giabbai, G. Garau, and M. Degano, Energy landscapes associated with macromolecular conformational changes from endpoint structures, J. Am. Chem. Soc., 132 (2010) 17570-17577.
339. M.-C. Ho, W. Shi, A. Rinaldo-Matthis, P. C. Tyler, G. B. Evans, K. Clinch, S. C. Almo, and V. L. Schramm, Four generations of transition-state analogues for human purine nucleoside hydrolase, Proc. Natl. Acad. Sci. USA, 107 (2010) 4805-4812.
340. R. Guan, M.-C. Ho, S. C. Almo, and V. L. Schramm, Methylthioinosine phosphorylase from Pseudomonas aeruginosa. Structure and annotation of a novel enzyme in quorum sensing, Biochemistry, 50 (2011) 1247-1254.
341. J. A. Gutierrez, T. Crowder, A. Rinaldo-Matthis, M.-C. Ho, S. C. Almo, and V. L. Schramm, Transition state analogs of 5'-methylthioadenosine nucleosidase disrupt quorum sensing, Nat. Chem. Biol., 5 (2009) 251-257.
342. J. A. R. Mead, J. W. Smith, and R. T. Williams, Detoxication (LXVII). Biosynthesis of the glucuronides of umbelliferone and 4-methylumbelliferone and their use in fluorimetric determination of β-glucuronidase, Biochem. J., 61 (1955) 569-574.
343. I. J. Goldstein and R. N. Iyer, Interaction of concanavalin A, a phytohemagglutinin, with model substrates, Biochim. Biophys. Acta, 121 (1966) 197-200.
344. J. Langridge, Mutations conferring quantitative and qualitative increases in β-galactosidase activity in Escherichia coli, Mol. Gen. Genet., 105 (1969) 74-83.
345. M. Yde, C. K. De Bruyne, and F. G. Loontiens, Study of the binding of 1-thio-β-D-galactosides on β-galactosidase from E. coli, Arch. Int. Physiol. Biochim., 84 (1976) 210-211.
346. M. Yde and C. K. De Bruyne, Binding of substituted phenyl 1-thio-β-D-galactopyranosides to β-D-galactosidase from E. coli, Carbohydr. Res., 60 (1978) 155-165.
347. G. Legler and H. Liedtke, Glucosylceramidase from calf spleen. Characterization of its active site with 4-n-alkylumbelliferyl β-glucosides and N-alkyl derivatives of 1-deoxynojirimycin, Biol. Chem. Hoppe Seyler, 366 (1985) 1113-1122.
348. G. M. Aerts, O. Van Opstal, and C. K. De Bruyne, Mixed inhibition of β-D-glucosidase from Stachybotrys atra by substrate analogues, Carbohydr. Res., 138 (1985) 127-134.
349. N. Baggett, M. A. Case, P. R. Darby, and C. J. Cray, Action of almond β-D-glucosidase on fluorogenic substrates derived from 4-substituted 7-hydroxycoumarins, Enzyme Microb. Technol., 15 (1993) 742-748.
350. M. P. Dale, H. E. Ensley, K. Kern, K. A. R. Shastry, and L. D. Byers, Reversible inhibitors of β-glucosidase, Biochemistry, 24 (1985) 3530-3539.
351. Y.-K. Li, H.-S. Hsu, L.-F. Chang, and G. Chen, New imidazoles as probes of the active site topology and potent inhibitors of β-glucosidase, J. Biochem., 123 (1998) 416-422.
352. S. J. Charnock, T. D. Spurway, H. Xie, M.-H. Beylot, R. Virden, R. A. J. Warren, G. P. Hazlewood, and H. J. Gilbert, The topology of the substrate binding clefts of glycosyl hydrolase family 10 xylanases are not conserved, J. Biol. Chem., 273 (1998) 32187-32199.
353. M. Czjzek, M. Cicek, V. Zamboni, D. R. Bevan, B. Henrissat, and A. Esim, The mechanism of substrate (aglycon) specificity in β-glucosidases is revealed by crystal structures of mutant maize β-glucosidase-DIMBOA, -DIMBOAGlc, and -dhurrin complexes, Proc. Natl. Acad. Sci. USA, 97 (2000) 13555-13560.
354. L. Verdoucq, J. Moriniere, D. R. Bevan, A. Esen, A. Vasella, B. Henrissat, and M. Czjzek, Structural determinants for substrate specificity in family 1 β-glucosidases, J. Biol. Chem., 279 (2004) 31796-31803.
355. H. Murai, H. Enomoto, Y. Aoyagi, Y. Yoshikuni, M. Yagi, and I. Shirahase, N-Alkylpiperidine derivatives. German Pat. DE 2824781 A1 19790104.
356. Stoltefuss, J. 1-Deoxynojirimycin and N-substituted derivatives. Eur. Pat. 1979-102174 19790629.
357. J. Schweden, C. Borgmann, G. Legler, and E. Bause, Characterization of calf liver glucosidase I and its inhibition by basic sugar analogs, Arch. Biochem. Biophys., 248 (1986) 335-340.
358. G. W. J. Fleet, A. Karpas, R. A. Dwek, L. E. Fellows, A. S. Tyms, S. Petursson, S. K. Namgoong, N. G. Ramsden, P. W. Smith, J. C. Son, F. Wilson, D. R. Witty, G. S. Jacob, and T. W. Rademacher, Inhibition of HIV replication by amino-sugar derivatives, FEBS Lett., 237 (1988) 128-132.
359. B. Lesur, J.-B. Ducep, M.-N. Lalloz, A. Ehrhard, and C. Danzin, New deoxynojirimycin derivatives as potent inhibitors of intestinal α-glucohydrolases, Bioorg. Med. Chem. Lett., 3 (1997) 355-360.
360. D. S. Alonzi, R. A. Dwek, and T. D. Butters, Improved cellular inhibitors for glycoprotein processing α-glucosidases: Biological characterisation of alkyl- and arylalkyl-N-substituted deoxynojirimycins, Tetrahedron: Asymmetry, 20 (2009) 897-901.
361. K. Osiecki-Newman, D. Fabbro, G. Legler, R. J. Desnick, and G. A. Grabowski, Human acid β-glucosidase: Use of inhibitors, alternative substrates and amphiphiles to investigate the properties of the normal and Gaucher disease active sites, Biochim. Biophys. Acta, 915 (1987) 87-100.
362. G. Legler and E. Bieberich, Isolation of cytosolic β-glucosidase from calf liver and characterization of its active site with alkyl glucosides and basic glycosyl derivatives, Arch. Biochem. Biophys., 260 (1988) 427-436.
363. H. S. Overkleeft, G. H. Renkema, J. Neele, P. Vianello, I. O. Hung, A. Strijland, A. M. van der Burg, G.-J. Koomen, U. K. Pandit, and J. M. F. G. Aerts, Generation of specific deoxynojirimycin-type inhibitors of the non-lysosomal glucoceramidase, J. Biol. Chem., 273 (1998) 26522-26527.
364. L. G. Dickson, E. Leroy, and J.-L. Reymond, Structure-activity relationships in aminocyclopentitol glycosidase inhibitors, Org. Biomol. Chem., 2 (2004) 1217-1226.
365. T. D. Butters, L. A. G. M. Van den Broek, G. W. J. Fleet, T. M. Krulle, M. R. Wormald, R. A. Dwek, and F. M. Platt, Molecular requirements of iminosugars for the selective control of N-linked glycosylation and glycosphingolipid biosynthesis, Tetrahedron: Asymmetry, 11 (2000) 113-124.
366. T. M. Wrodnigg, F. Diness, C. Gruber, H. Häusler, I. Lundt, K. Rupitz, A. J. Steiner, A. E. Stütz, C. A. Tarling, S. G. Withers, and H. Wölfler, Probing the aglycon binding site of a β-glucosidase: A collection of C-1-modified 2,5-dideoxy-2,5-imino-D-mannitol derivatives and their structure-activity relationships as competitive inhibitors, Bioorg. Med. Chem., 12 (2004) 3485-3495.
367. T. M. Wrodnigg, A. E. Stütz, C. A. Tarling, and S. G. Withers, Fine tuning of β-glucosidase inhibitory activity in the 2,5-dideoxy-2,5-imino-D-mannitol (DMDP) system, Carbohydr. Res., 341 (2006) 1717-1722.
368. A. R. Sawkar, S. L. Adamski-Werner, W.-C. Cheng, C.-H. Wong, E. Beutler, K.-P. Zimmer, and J. W. Kelly, Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles, Chem. Biol., 12 (2005) 1235-1244.
369. Z. Yu, A. R. Sawkar, L. J. Whalen, C.-H. Wong, and J. W. Kelly, Isofagomine- and 2,5-anhydro-2,5-imino-D-glucitol based glucocerebrosidase pharmacological chaperones for Gaucher disease prevention, J. Med. Chem., 50 (2007) 94-100.
370. L. Yu, K. Ikeda, A. Kato, I. Adachi, G. Godin, P. Compain, O. Martin, and N. Asano, α-1-C-Octyl-1-deoxynojirimycin as a pharmacological chaperone for Gaucher disease, Bioorg. Med. Chem., 14 (2006) 7736-7744.
371. P. Compain, O. R. Martin, C. Boucheron, G. Godin, L. Yu, K. Ikeda, and N. Asano, Design and synthesis of highly potent and selective pharmacological chaperones for the treatment of Gaucher disease, Chembiochem, 7 (2006) 1356-1359.
372. F. Oulaidi, S. Front-Deschamps, E. Gallienne, E. Lesellier, K. Ikeda, N. Asano, P. Compain, and O. R. Martin, Second-generation iminoxylitol-based pharmacological chaperones for the treatment of Gaucher disease, ChemMedChem, 6 (2011) 353-361.
373. T. Wennekes, R. J. B. H. N. van den Berg, W. Donker, G. A. van der Marel, A. Strijland, J. M. F. G. Aerts, and H. S. Overkleeft, Development of adamantan-1-yl-methoxy-functionalised 1-deoxynojirimycin derivatives as selective inhibitors of glucosylceramide metabolism in man, J. Org. Chem., 72 (2007) 1088-1097.
374. T. Wennekes, R. J. B. H. N. van den Berg, T. J. Boltje, W. E. Donker-Koopman, B. Kuijper, G. J. A. van der Marel, A. Strijland, C. P. Verhagen, J. M. F. G. Aerts, and H. S. Overkleeft, Synthesis and evaluation of lipophilic aza-C-glycosides as inhibitors of glucosylceramide metabolism, Eur. J. Org. Chem. (2010) 1258-1283.
375. E. M. Sanchez-Fernandez, R. Risquez-Cuadro, M. Chasseraud, A. Ahidouch, C. Ortiz Mellet, H. Ouadid-Ahidouch, and J. M. Garcia Fernandez, Synthesis of N-, S-, and C-glycoside castanospermine analogues with selective neutral α-glucosidase inhibitory activity as antitumour agents, Chem. Commun., 46 (2010) 5328-5330.
376. M. Aguilar-Moncayo, M. I. Garcia-Moreno, A. Trapero, M. Egido-Gabas, A. Llebaria, J. M. Garcia Fernandez, and C. Ortiz Mellet, Bicyclic (galacto)nojiriymcin analogues as glycosidase inhibitors: Effect of structural modifications in their pharmacological chaperone potential towards β-glucocerebrosidase, Org. Biomol. Chem., 9 (2011) 3698-3713.
377. H. Häusler, K. Rupitz, A. E. Stütz, and S. G. Withers, N-Alkylated derivatives of 1,5-dideoxy-1,5-iminoxylitol as β-xylosidase and β-glucosidase inhibitors, Chem. Monthly, 133 (2002) 555-560.
378. C.-F. Chang, C.-W. Ho, C.-Y. Wu, T.-A. Chao, C.-H. Wong, and C.-H. Lin, Discovery of picomolar slow tight-binding inhibitors of α-fucosidase, Chem. Biol., 11 (2004) 1301-1306.
379. C.-W. Ho, Y.-N. Lin, C.-F. Chang, S.-T. Li, Y.-T. Wu, C.-Y. Wu, C.-F. Chang, S.-W. Liu, Y.-K. Li, and C.-H. Lin, Discovery of different types of inhibition between the human and Thermotoga maritima α-fucosidases by fuconojirimycin-based derivatives, Biochemistry, 45 (2006) 5695-5702.
380. P.-H. Liang, W.-C. Cheng, Y.-L. Lee, H.-P. Yu, Y.-T. Wu, Y.-L. Lin, and C.-H. Wong, Novel fivemembered iminocyclitol derivatives as selective and potent glycosidase inhibitors: New structures for antivirals and osteoarthritis, ChemBioChem, 7 (2006) 165-167.
381. G. Schitter, A. J. Steiner, G. Pototschnig, E. Scheucher, M. Thonhofer, C. A. Tarling, S. G. Withers, K. Fantur, E. Paschke, D. J. Mahuran, B. A. Rigat, M. B. Tropak, C. Illaszewicz, R. Saf, A. E. Stütz, and T. M. Wrodnigg, Fluorous iminoalditols: A new family of glycosidase inhibitors and pharmacological chaperones, ChemBioChem, 11 (2010) 2026-2033.
382. A. Ghisaidoobe, P. Bikker, A. C. J. de Bruijn, F. D. Godschalk, E. Rogaar, M. C. Guijt, P. Hagens, J. M. Halma, S. M. van't Hart, S. B. Luitjens, V. H. S. van Rixel, M. Wijzenbroek, T. Zweegers, W. E. Donker-Koopman, A. Strijland, R. Boot, G. van der Marel, H. S. Overkleeft, J. M. F. G. Aerts, and R. J. B. H. N. van den Berg, ACS Med. Chem. Lett., 2 (2011) 119-123.
383. A. Hermetter, H. Scholze, A. E. Stütz, S. G. Withers, and T. M. Wrodnigg, Powerful probes for glycosidases: Novel, fluorescently tagged glycosidase inhibitors, Bioorg. Med. Chem. Lett., 11 (2001) 1339-1342.
384. P. Greimel, H. Häusler, I. Lundt, K. Rupitz, A. E. Stütz, C. A. Tarling, S. G. Withers, and T. M. Wrodnigg, Fluorescent glycosidase inhibiting 1,5-dideoxy-1,5-iminoalditols, Bioorg. Med. Chem. Lett., 16 (2006) 2067-2070.
385. I. Lundt, A. J. Steiner, A. E. Stütz, C. A. Tarling, S. Ully, S. G. Withers, and T. M. Wrodnigg, Fluorescently tagged iminoalditol glycosidase inhibitors as novel biological probes and diagnostics, Bioorg. Med. Chem., 14 (2006) 1737-1742.
386. A. J. Steiner, A. E. Stütz, C. A. Tarling, S. G. Withers, and T. M. Wrodnigg, Iminoalditol-amino acid hybrids: Synthesis and evaluation as glycosidase inhibitors, Carbohydr. Res., 342 (2007) 1850-1858.
387. A. J. Steiner, G. Schitter, A. E. Stütz, T. M. Wrodnigg, C. A. Tarling, S. G. Withers, K. Fantur, D. Mahuran, E. Paschke, and M. Tropak, 1-Deoxygalactonojirimycin-lysine hybrids as potent D-galactosidase inhibitors, Bioorg. Med. Chem., 16 (2008) 10216-10220.
388. A. J. Steiner, A. E. Stütz, T. M. Wrodnigg, C. A. Tarling, S. G. Withers, A. Hermetter, and H. Schmidinger, Glycosidase profiling with immobilized glycosidase-inhibiting iminoalditols-A proof-of-concept study, Bioorg. Med. Chem. Lett., 18 (2008) 1922-1925.
389. A. J. Rawlings, H. Lomas, A. W. Pilling, M. J.-R. Lee, D. S. Alonzi, J. S. S. Rountree, S. F. Jenkinson, G. W. J. Fleet, R. A. Dwek, J. H. Jones, and T. D. Butters, Synthesis and biological characterisation of novel N-alkyl-deoxynojirimycin α-glucosidase inhibitors, ChemBioChemm, 10 (2009) 1101-1105.
390. M. Van Scherpenzeel, R. J. B. H. N. van den Berg, W. E. Donker-Koopman, R. M. J. Liskamp, J. M. F. G. Aerts, H. S. Overkleeft, and R. J. Pieters, Nanomolar affinity, aminosugar based chemical probes for specific labeling of lysosomal glucocerebrosidase, Bioorg. Med. Chem., 18 (2010) 267-273.
391. M. N. Gandy, A. W. Debowski, and K. A. Stubbs, A general method for affinity-based proteomic profiling of exo-α-glucosidases, Chem. Commun., 47 (2011) 5037-5039.
392. 2-iminosugars with potent β-glucosidase inhibitory activity, Bioorg. Med. Chem., 18 (2010) 7439-7445.
393. 2-iminosugar with pharmacological chaperone activity for Gaucher disease: Synthesis and intracellular distribution studies, ChemBioChem, 11 (2010) 2453-2464.
394. G. Pototschnig, C. Morales de Csaky, J. R. Montenegro Burke, G. Schitter, A. E. Stütz, C. A. Tarling, S. G. Withers, and T. M. Wrodnigg, Synthesis and biological evaluation of novel biotin-iminoalditol conjugates, Bioorg. Med. Chem. Lett., 20 (2010) 4077-4079.
395. G. Schitter, E. Scheucher, A. J. Steiner, A. E. Stütz, M. Thonhofer, C. A. Tarling, S. G. Withers, J. Wicki, K. Fantur, E. Paschke, D. J. Mahuran, B. A. Rigat, M. Tropak, and T. M. Wrodnigg, Synthesis of lipophilic 1-deoxygalactonojirimycin derivatives as D-galactose inhibitors, Beilstein J. Org. Chem., 6(2010) No. 21.
396. A. M. C. H. van den Nieuwendijk, M. Ruben, S. E. Engelsma, M. D. P. Risseeuw, R. J. B. H. N. van den Berg, R. G. Boot, J. M. Aerts, J. Brussee, G. A. van der Marel, and H. Overkleeft, Synthesis of L-altro-1-deoxynojirimycin, D-allo-1-deoxynojirimycin, and D-galacto-1-deoxynojirimycin from a single chiral cyanohydrin, Org. Lett., 12 (2010) 3957-3959.
397. A. Guaragna, D. D'Alonzo, C. Paolella, and G. Palumbo, Synthesis of 1-deoxy-L-gulonojirimycin and 1-deoxy-L-talonojirimycin, Tetrahedron Lett., 50 (2009) 2045-2047.
398. M. Ganesan and N. G. Ramesh, A new and short synthesis of naturally occurring 1-deoxy-L-gulonojirimycin from tri-O-benzyl-D-glucal, Tetrahedron Lett., 51 (2010) 5574-5576.
399. M. Ruiz, T. M. Ruanova, O. Blanco, F. Nunez, C. Pato, and V. Ojea, Diastereoselective synthesis of piperidine imino sugars using aldol additions of metalated bislactim ethers to threose and erythrose acetonides, J. Org. Chem., 73 (2008) 2240-2255.
400. B. La Ferla, P. Bugada, and F. Nicotra, Synthesis of the dimethyl ester of 1-deoxy-L-idonojirimycin-1-methylenephosphonate: A new approach to iminosugar phosphonates, J. Carbohydr. Chem., 25 (2006) 151-162.
401. A. Ak, S. Prudent, D. LeNouen, A. Defoin, and C. Tarnus, Synthesis of all-cis 2,5-imino-2,5-dideoxyfucitol and its evaluation as a potent fucosidase and galactosidase inhibitor, Bioorg. Med. Chem. Lett., 20 (2010) 7410-7413.
402. C.-Y. Yu, N. Asano, K. Ikeda, M.-X. Wang, T. D. Butters, M. R. Wormald, R. A. Dwek, A. L. Winters, R. J. Nash, and G. W. J. Fleet, Looking glass inhibitors: L-DMDP, a more potent and specific inhibitor of α-glucosidase than the enantiomeric natural product DMDP, Chem. Commun. (2004) 1936-1937.
403. Y. Berliot, D. Gretzke, T. M. Krulle, T. D. Butters, R. A. Dwek, R. J. Nash, N. Asano, and G. W. J. Fleet, Looking glass inhibitors: Efficient synthesis and biological evaluation of D-fuconojirimycin, Carbohydr. Res., 340 (2005) 2713-2718.
404. A. E. Hakansson, J. van Ameijde, L. Guglielmini, G. Horne, R. J. Nash, E. L. Evinson, A. Kato, and G. W. J. Fleet, Looking glass inhibitors: Synthesis of a potent naringinase inhibitor L-DIM (1,4-dideoxy-1,4-imino-L-mannitol), the enantiomer of DIM (1,4-dideoxy-1,4-imino-D-mannitol) a potent α-D-mannosidase inhibitor, Tetrahedron: Asymmetry, 18 (2007) 282-289.
405. T. B. Mercer, S. F. Jenkinson, B. Bartholomew, R. J. Nash, S. Miyauchi, A. Kato, and G. W. J. Fleet, Looking glass inhibitors: Bote enantiomeric N-benzyl derivatives of 1,4-dideoxy-1,4-imino-D-lyxitol (a potent competitive inhibitor of α-D-galactosidase) and of 1,4-dideoxy-1,4-imino-L-lyxitol (a weak competitive inhibitor of α-D-galactosidase) inhibit naringinase, an α-L-rhamnosidase competitively, Tetrahedron: Asymmetry, 20 (2009) 2368-2373.
406. D. D'Alonzo, A. Guaragna, and G. Palumbo, Glycomimetics at the mirror: Medicinal chemistry of L-iminosugars, Curr. Med. Chem., 16 (2009) 473-505.
407. D. Best, C. Wang, A. C. Weymouth-Wilson, R. A. Clarkson, F. X. Wilson, R. J. Nash, S. Miyauchi, A. Kato, and G. W. J. Fleet, Looking glass inhibitors: Scalable syntheses of DNJ, DMDP, and (3R)-3-hydroxy-L-bulgecinine from D-glucuronolactone and of L-DNJ, L-DMDP, and (3S)-3-hydroxy-D-bulecinine from L-glucuronolactone. DMDP inhibits β-glucosidases and β-galactosidases whereas L-DMDP is a potent and specific inhibitor of α-glucosidases, Tetrahedron: Asymmetry, 21 (2010) 311-319.
408. J.-Q. Fan, Iminosugars as active-site-specific chaperones for the treatment of lysosomal storage disorders, in P. Compain and O. R. Martin, (Eds.), Iminosugars: From Synthesis to Therapeutic Applications, Wiley, Chichester, 2007, pp. 225-247.
409. P. Compain, V. Desvergnes, V. Liautard, C. Pillard, and S. Toumieux, Tables of iminosugars, their biological activities and their potential as therapeutic agents, in P. Compain and O. R. Martin, (Eds.), Iminosugars: From Synthesis to Therapeutic Applications, Wiley, Chichester, 2007, pp. 327-455.
410. O. Martin, Iminosugars: Current and future therapeutic applications, Ann. Pharm. Fr., 65 (2007) 5-13.
411. T. M. Wrodnigg, A. J. Steiner, and B. J. Überbacher, Natural and synthetic iminosugars as carbohydrate processing enzyme inhibitors for cancer therapy, Anticancer Agents Med. Chem., 8 (2008) 77-85.
412. G. Horne, F. X. Wilson, J. Tinsley, D. H. Williams, and R. Storer, Iminosugars past, present and future: Medicines for tomorrow, Drug Discov. Today, 16 (2011) 107-118.
413. R. Zhang, W. Zhang, and T. Hu, Dextran glucosidase: A potential target of iminosugars in caries prevention, Med. Hypotheses, 76 (2011) 574-575.